https://novapharmanews.com/us/news/altrx-glp-1-review-2026-fda-updates-semaglutide 2026-06-03T05:26:32.547Z weekly 0.7 https://novapharmanews.com/us/news/chinese-pharma-innovators-global-expansion 2026-06-03T04:52:03.832Z weekly 0.7 https://novapharmanews.com/us/news/global-ma-trends-health-industries-2026-outlook 2026-06-03T04:51:59.828Z weekly 0.7 https://novapharmanews.com/us/news/pennsylvania-compounding-pharmacy-fda-warning-letter 2026-06-03T04:51:57.819Z weekly 0.7 https://novapharmanews.com/us/news/resilience-reinvention-biotech-maturity 2026-06-03T04:51:55.817Z weekly 0.7 https://novapharmanews.com/us/news/wockhardt-us-fda-approval-zaynich 2026-06-03T04:51:53.811Z weekly 0.7 https://novapharmanews.com/us/news/china-drug-development-oncology-us 2026-06-03T04:51:51.825Z weekly 0.7 https://novapharmanews.com/us/news/longeveron-q1-2026-financial-results-business-update 2026-06-03T04:51:49.814Z weekly 0.7 https://novapharmanews.com/us/news/china-approves-hernexeos-lung-cancer-treatment 2026-06-03T04:51:48.671Z weekly 0.7 https://novapharmanews.com/us/news/vir-astellas-240m-prostate-cancer-trials 2026-06-03T04:51:47.978Z weekly 0.7 https://novapharmanews.com/us/news/fda-decisions-q2-2026-drug-approvals 2026-06-03T04:51:45.717Z weekly 0.7 https://novapharmanews.com/us/news/jpm26-biotech-ma-insights-market-analysis 2026-06-03T04:51:43.718Z weekly 0.7 https://novapharmanews.com/us/news/lilly-38b-investment-infectious-disease-portfolio 2026-06-03T05:29:47.035Z weekly 0.7 https://novapharmanews.com/apac/news/asia-pacific-eclinical-solutions-market-report-2025-2030 2026-06-03T05:28:10.106Z weekly 0.7 https://novapharmanews.com/apac/news/biomarkers-digital-technologies-oncology-asia-2026 2026-06-03T05:12:48.737Z weekly 0.7 https://novapharmanews.com/eu/news/owkin-astrazeneca-ai-collaboration-drug-research 2026-06-03T04:53:35.745Z weekly 0.7 https://novapharmanews.com/us/news/fda-blueprint-regulatory-risk-animal-testing-alternatives 2026-06-03T04:52:39.874Z weekly 0.7 https://novapharmanews.com/eu/news/privosegtor-ema-prime-optic-neuritis 2026-06-03T04:52:35.858Z weekly 0.7 https://novapharmanews.com/us/news/fda-new-guidance-ai-regulatory-restraint 2026-06-03T04:52:31.853Z weekly 0.7 https://novapharmanews.com/eu/news/esmo-asia-nadia-harbeck-oncology-advances 2026-06-03T04:52:29.852Z weekly 0.7 https://novapharmanews.com/apac/news/innovative-oncology-pharma-china 2026-06-03T04:52:27.861Z weekly 0.7 https://novapharmanews.com/eu/news/arrowhead-pharmaceuticals-positive-clinical-data-eas-congress 2026-06-03T04:52:26.091Z weekly 0.7 https://novapharmanews.com/us/news/fda-device-guidance-agenda-2026 2026-06-03T04:52:21.839Z weekly 0.7 https://novapharmanews.com/apac/news/uk-clinical-trials-oncology-impact 2026-06-03T04:52:19.839Z weekly 0.7 https://novapharmanews.com/eu/news/innovent-pfizer-cancer-drug-deal 2026-06-03T04:52:17.833Z weekly 0.7 https://novapharmanews.com/apac/news/smarter-medical-devices-ecosystem-india-regulatory-updates 2026-06-03T04:52:15.840Z weekly 0.7 https://novapharmanews.com/eu/news/innovent-biologics-shares-surge-pfizer-deal 2026-06-03T04:52:13.920Z weekly 0.7 https://novapharmanews.com/eu/news/cancer-therapy-ost-her2-2026-ema-call 2026-06-03T04:52:11.836Z weekly 0.7 https://novapharmanews.com/eu/news/chmp-negative-stance-acadia-rett-syndrome-drug 2026-06-03T04:52:09.928Z weekly 0.7 https://novapharmanews.com/eu/news/lenz-therapeutics-vizz-ema-presbyopia 2026-06-03T04:52:07.824Z weekly 0.7 https://novapharmanews.com/us/news/lunai-bioworks-brainstorm-therapeutics-ai-collaboration 2026-06-03T04:52:43.896Z weekly 0.7 https://novapharmanews.com/eu/news/chmp-may-2026-output-shift-european-drug-development 2026-06-03T04:52:41.866Z weekly 0.7 https://novapharmanews.com/us/news/editas-medicine-inc-stock-quiet-trading-clinical-trials 2026-06-03T05:28:10.667Z weekly 0.7 https://novapharmanews.com/us/news/ai-breast-cancer-risk-prediction-tool-fda-approval 2026-06-03T05:00:11.861Z weekly 0.7 https://novapharmanews.com/us/news/bizengri-fda-national-priority-rare-bile-duct-cancer 2026-06-03T04:53:31.356Z weekly 0.7 https://novapharmanews.com/us/news/ai-brain-organoids-parkinsons-rare-epilepsy-regulatory-updates 2026-06-03T04:53:13.927Z weekly 0.7 https://novapharmanews.com/us/news/vir-biotechnology-stock-board-reshuffle-governance-votes 2026-06-03T04:53:11.908Z weekly 0.7 https://novapharmanews.com/us/news/big-pharma-biotech-assets-patent-cliff 2026-06-03T04:53:07.894Z weekly 0.7 https://novapharmanews.com/us/news/fda-commissioner-resignation-drug-approvals 2026-06-03T04:53:05.901Z weekly 0.7 https://novapharmanews.com/us/news/big-pharma-ma-spree-march-ipo-drought 2026-06-03T04:52:59.881Z weekly 0.7 https://novapharmanews.com/us/news/pharma-ma-boom-2026-market-analysis 2026-06-03T04:52:57.884Z weekly 0.7 https://novapharmanews.com/us/news/regeneron-fda-approval-neurosensory-gene-therapy 2026-06-03T04:52:55.876Z weekly 0.7 https://novapharmanews.com/us/news/pharmtech-regulatory-roundup-may-2026-drug-approvals 2026-06-03T04:52:53.871Z weekly 0.7 https://novapharmanews.com/us/news/regulatory-actions-may-2026 2026-06-03T04:52:51.883Z weekly 0.7 https://novapharmanews.com/us/news/states-confront-medical-chatbots-oversight-fda-inaction 2026-06-03T04:52:49.875Z weekly 0.7 https://novapharmanews.com/us/news/life-sciences-dealmaking-momentum-strategic-pressures 2026-06-03T04:52:47.959Z weekly 0.7 https://novapharmanews.com/us/news/pfizer-innovent-deal-global-drug-development-oncology 2026-06-03T04:52:45.871Z weekly 0.7 https://novapharmanews.com/apac/news/onconic-therapeutics-jakubo-phase-3-clinical-trials-china 2026-06-03T04:53:45.927Z weekly 0.7 https://novapharmanews.com/eu/news/imfinzi-approval-bladder-cancer 2026-06-03T04:53:43.935Z weekly 0.7 https://novapharmanews.com/eu/news/esmo-2025-preview-astra-daiichi-gilead 2026-06-03T04:53:41.933Z weekly 0.7 https://novapharmanews.com/apac/news/innovent-biologics-pfizer-10-5b-oncology-partnership 2026-06-03T04:53:39.944Z weekly 0.7 https://novapharmanews.com/eu/news/2026-cell-therapy-regulatory-landscape 2026-06-03T04:53:37.925Z weekly 0.7 https://novapharmanews.com/eu/news/pfizer-innovent-10-5bn-oncology-deal 2026-06-03T04:53:35.929Z weekly 0.7 https://novapharmanews.com/eu/news/critical-medicines-act-council-parliament-deal 2026-06-03T04:53:33.963Z weekly 0.7 https://novapharmanews.com/eu/news/merz-therapeutics-kvvit-inbrija-agreement 2026-06-03T04:53:31.931Z weekly 0.7 https://novapharmanews.com/eu/news/pfizer-innovent-cancer-drug-alliance 2026-06-03T04:53:29.919Z weekly 0.7 https://novapharmanews.com/apac/news/premia-lind-ai-clinical-trial-screening-asia-pacific 2026-06-03T04:53:27.923Z weekly 0.7 https://novapharmanews.com/apac/news/cell-gene-therapy-approvals-china-regulatory-updates 2026-06-03T04:53:25.920Z weekly 0.7 https://novapharmanews.com/eu/news/imfinzi-fda-approval-bladder-cancer 2026-06-03T04:53:23.918Z weekly 0.7 https://novapharmanews.com/eu/news/pfizer-innovent-105bn-adc-oncology-partnership 2026-06-03T04:53:21.919Z weekly 0.7 https://novapharmanews.com/apac/news/clinical-trials-market-oncology-2034 2026-06-03T04:53:19.911Z weekly 0.7 https://novapharmanews.com/eu/news/prac-meeting-highlights-may-2026 2026-06-03T04:53:17.904Z weekly 0.7 https://novapharmanews.com/apac/news/regulatory-round-up-drug-approvals-april-20-2026 2026-06-03T04:53:15.900Z weekly 0.7 https://novapharmanews.com/us/news/seven-biopharma-trends-2026-clinical-trials 2026-06-03T05:32:12.601Z weekly 0.7 https://novapharmanews.com/apac/news/global-drug-discovery-market-2035 2026-06-03T04:54:01.954Z weekly 0.7 https://novapharmanews.com/us/news/experimental-igg4-rd-drug-fda-submission 2026-06-03T04:53:57.948Z weekly 0.7 https://novapharmanews.com/apac/news/middle-east-pharma-markets-api-china-2026 2026-06-03T04:53:55.955Z weekly 0.7 https://novapharmanews.com/apac/news/sun-pharma-organon-acquisition-market-analysis 2026-06-03T04:53:53.945Z weekly 0.7 https://novapharmanews.com/us/news/fda-approves-durvalumab-bcg-high-risk-nmibc 2026-06-03T04:53:51.941Z weekly 0.7 https://novapharmanews.com/us/news/leap-therapeutics-stock-edges-higher 2026-06-03T04:53:49.947Z weekly 0.7 https://novapharmanews.com/us/news/longeveron-fda-meeting-elpis-ii-data 2026-06-03T04:53:47.940Z weekly 0.7 https://novapharmanews.com/eu/news/camizestrant-eu-approval-advanced-er-positive-breast-cancer 2026-06-03T05:34:53.861Z weekly 0.7 https://novapharmanews.com/apac/news/apac-clinical-trial-growth-oncology 2026-06-03T04:54:39.192Z weekly 0.7 https://novapharmanews.com/apac/news/regulatory-strategy-reimagined-trends-accelerating-drug-development 2026-06-03T04:54:38.390Z weekly 0.7 https://novapharmanews.com/us/news/us-fda-decision-date-camizestrant-extended 2026-06-03T04:54:35.991Z weekly 0.7 https://novapharmanews.com/apac/news/big-pharma-china-trials-scrutiny-oncology 2026-06-03T04:54:33.992Z weekly 0.7 https://novapharmanews.com/us/news/global-firms-china-deals-economic-uncertainty 2026-06-03T04:54:31.988Z weekly 0.7 https://novapharmanews.com/eu/news/hansa-licenses-idefirix-serb-133m 2026-06-03T04:54:27.977Z weekly 0.7 https://novapharmanews.com/apac/news/exosome-based-therapeutics-market-2033-report 2026-06-03T04:54:23.993Z weekly 0.7 https://novapharmanews.com/us/news/fda-loosens-regulations-digital-health-tools 2026-06-03T04:54:21.982Z weekly 0.7 https://novapharmanews.com/eu/news/critical-medicines-act-europe-medicines-shortages 2026-06-03T04:54:19.966Z weekly 0.7 https://novapharmanews.com/eu/news/tarsier-pharma-ipo-nyse-listings-expand 2026-06-03T04:54:17.983Z weekly 0.7 https://novapharmanews.com/eu/news/definitive-trial-milestone-50-percent-recruitment 2026-06-03T04:54:15.968Z weekly 0.7 https://novapharmanews.com/eu/news/liquid-biopsy-breast-cancer-improvements 2026-06-03T04:54:13.965Z weekly 0.7 https://novapharmanews.com/eu/news/ema-management-board-march-2026-clinical-trials 2026-06-03T04:54:11.964Z weekly 0.7 https://novapharmanews.com/apac/news/ai-tools-clinical-trials-life-sciences 2026-06-03T04:54:09.970Z weekly 0.7 https://novapharmanews.com/us/news/gsk-alfasigma-licensing-agreement-servier-acquisition 2026-06-03T04:54:07.977Z weekly 0.7 https://novapharmanews.com/eu/news/imfinzi-approved-bladder-cancer-combo 2026-06-03T04:54:06.056Z weekly 0.7 https://novapharmanews.com/us/news/biopharma-dealmaking-2025-market-analysis 2026-06-03T04:54:03.955Z weekly 0.7 https://novapharmanews.com/us/news/eli-lilly-acquires-vaccine-developers-38b 2026-06-03T04:54:47.995Z weekly 0.7 https://novapharmanews.com/eu/news/ai-accelerates-novo-nordisk-parkinsons-cell-therapy 2026-06-03T04:54:45.993Z weekly 0.7 https://novapharmanews.com/apac/news/hanmi-pharma-organon-partnership-southeast-asia 2026-06-03T04:54:44.000Z weekly 0.7 https://novapharmanews.com/apac/news/regulatory-round-up-drug-approvals-18-may-2026 2026-06-03T04:54:42.461Z weekly 0.7 https://novapharmanews.com/eu/news/european-critical-medicines-act-market-analysis 2026-06-03T04:54:40.028Z weekly 0.7 https://novapharmanews.com/apac/news/leaders-shape-future-healthcare-asgh-2026 2026-06-03T05:16:34.195Z weekly 0.7 https://novapharmanews.com/apac/news/india-vietnam-relations-diplomatic-push 2026-06-03T04:55:10.024Z weekly 0.7 https://novapharmanews.com/us/news/lifesaving-upgrades-fda-oncology-approvals 2026-06-03T04:55:08.031Z weekly 0.7 https://novapharmanews.com/apac/news/premia-lind-lind-asia-ai-clinical-trials 2026-06-03T04:55:06.016Z weekly 0.7 https://novapharmanews.com/us/news/fda-restricts-compounding-weight-loss-drugs 2026-06-03T04:55:04.019Z weekly 0.7 https://novapharmanews.com/apac/news/brenus-pharma-stc-1010-fda-acceptance 2026-06-03T04:55:02.033Z weekly 0.7 https://novapharmanews.com/us/news/neurosense-regulatory-advancements-alzheimers-trials 2026-06-03T04:55:01.128Z weekly 0.7 https://novapharmanews.com/us/news/top-10-anticipated-drug-launches-2026 2026-06-03T04:55:00.114Z weekly 0.7 https://novapharmanews.com/apac/news/immunotherapy-pet-ct-imaging-demand-australia 2026-06-03T04:54:58.005Z weekly 0.7 https://novapharmanews.com/us/news/astrazeneca-daiichi-drug-approval-breast-cancer 2026-06-03T04:54:54.020Z weekly 0.7 https://novapharmanews.com/us/news/fda-guidelines-generic-bioequivalence-oncology 2026-06-03T04:54:52.014Z weekly 0.7 https://novapharmanews.com/us/news/3-overlooked-stocks-soar-2026-clinical-trials 2026-06-03T04:54:50.016Z weekly 0.7 https://novapharmanews.com/eu/news/fda-real-time-clinical-trials-progress 2026-06-03T05:28:15.699Z weekly 0.7 https://novapharmanews.com/eu/news/us-eu-pharmaceutical-regulations-concerns 2026-06-03T04:55:48.149Z weekly 0.7 https://novapharmanews.com/apac/news/regulatory-updates-optical-coherence-tomography-pharma 2026-06-03T04:55:46.972Z weekly 0.7 https://novapharmanews.com/apac/news/nuance-pharma-ind-clearance-actair-china 2026-06-03T04:55:44.276Z weekly 0.7 https://novapharmanews.com/eu/news/hayes-esmo-breast-cancer-award-2026 2026-06-03T04:55:43.578Z weekly 0.7 https://novapharmanews.com/eu/news/key-cancer-drugs-esmo-2025 2026-06-03T04:55:38.055Z weekly 0.7 https://novapharmanews.com/eu/news/ema-fda-good-ai-practice-drug-development 2026-06-03T04:55:36.050Z weekly 0.7 https://novapharmanews.com/us/news/chinas-licensing-boom-global-pipelines 2026-06-03T04:55:34.048Z weekly 0.7 https://novapharmanews.com/eu/news/ema-accepts-teva-once-monthly-schizophrenia-shot 2026-06-03T04:55:32.049Z weekly 0.7 https://novapharmanews.com/us/news/fda-declines-guidance-foreign-drug-imports 2026-06-03T04:55:30.054Z weekly 0.7 https://novapharmanews.com/apac/news/blockbuster-drugs-patent-cliff-2026-oncology 2026-06-03T04:55:28.051Z weekly 0.7 https://novapharmanews.com/eu/news/europe-boost-clinical-trials 2026-06-03T04:55:26.063Z weekly 0.7 https://novapharmanews.com/eu/news/may-2026-global-health-wash-funding-opportunities 2026-06-03T04:55:24.038Z weekly 0.7 https://novapharmanews.com/us/news/industry-groups-fda-guidance-form-483 2026-06-03T04:55:22.045Z weekly 0.7 https://novapharmanews.com/us/news/fda-clarifies-3-year-exclusivity-guidance 2026-06-03T04:55:20.051Z weekly 0.7 https://novapharmanews.com/eu/news/eu-draft-deal-essential-medicine-shortages 2026-06-03T04:55:18.921Z weekly 0.7 https://novapharmanews.com/us/news/sgs-acquires-keystone-bioanalytical-drug-development 2026-06-03T04:55:18.034Z weekly 0.7 https://novapharmanews.com/eu/news/serd-therapy-anti-proliferative-activity-er-her2-breast-cancer 2026-06-03T04:55:14.030Z weekly 0.7 https://novapharmanews.com/us/news/fda-vs-ema-camizestrant-controversy 2026-06-03T04:56:06.181Z weekly 0.7 https://novapharmanews.com/us/news/astellas-xtandi-patent-cliff-strategic-moves 2026-06-03T04:56:05.839Z weekly 0.7 https://novapharmanews.com/eu/news/arrowhead-pharmaceuticals-positive-cardiometabolic-data-european-a 2026-06-03T04:56:04.161Z weekly 0.7 https://novapharmanews.com/eu/news/maat-pharma-q1-2026-business-update 2026-06-03T04:56:00.166Z weekly 0.7 https://novapharmanews.com/apac/news/60-degrees-pharmaceuticals-tafenoquine-clinical-trial-babesiosis 2026-06-03T04:55:58.172Z weekly 0.7 https://novapharmanews.com/apac/news/lundbeck-korean-approval-vyepti-oncology-migraine 2026-06-03T04:55:56.154Z weekly 0.7 https://novapharmanews.com/us/news/best-biotech-stocks-may-2026-clinical-trials 2026-06-03T04:55:54.159Z weekly 0.7 https://novapharmanews.com/eu/news/critical-medicines-act-impact-pharmaceutical-manufacturing-europe 2026-06-03T04:55:52.156Z weekly 0.7 https://novapharmanews.com/apac/news/bukwang-pharmaceutical-dreamcis-aws-clinical-trials 2026-06-03T04:55:50.140Z weekly 0.7 https://novapharmanews.com/eu/news/esmo-breast-cancer-congress-2026-highlights 2026-06-03T04:56:10.182Z weekly 0.7 https://novapharmanews.com/us/news/fda-new-form-483-response-guidance 2026-06-03T04:56:08.162Z weekly 0.7 https://novapharmanews.com/apac/news/clinical-trials-day-2026-oncology-study-growth 2026-06-03T04:56:28.183Z weekly 0.7 https://novapharmanews.com/apac/news/health-news-round-up-immunotherapy-pcos-clopidogrel-trials 2026-06-03T04:56:26.290Z weekly 0.7 https://novapharmanews.com/us/news/biomarin-swot-analysis-rare-disease-competitive-headwinds 2026-06-03T04:56:24.571Z weekly 0.7 https://novapharmanews.com/apac/news/datroway-approved-metastatic-tnbc 2026-06-03T04:56:24.199Z weekly 0.7 https://novapharmanews.com/us/news/liminatus-pharma-innocsai-merger-market-analysis 2026-06-03T04:56:22.910Z weekly 0.7 https://novapharmanews.com/us/news/fda-drug-approval-decisions-may-2026 2026-06-03T04:56:18.175Z weekly 0.7 https://novapharmanews.com/us/news/aurobindo-pharma-oai-classification-drug-approvals 2026-06-03T04:56:16.183Z weekly 0.7 https://novapharmanews.com/eu/news/ema-approves-novo-wegovy-weight-loss-drug 2026-06-03T04:56:14.173Z weekly 0.7 https://novapharmanews.com/eu/news/ireland-clinical-trials-eu-comparison 2026-06-03T04:56:12.175Z weekly 0.7 https://novapharmanews.com/eu/news/chmp-meeting-highlights-drug-approvals-april-2026 2026-06-03T04:56:30.186Z weekly 0.7 https://novapharmanews.com/eu/news/efpia-warns-access-gap-us-pricing-reforms 2026-06-03T05:33:30.814Z weekly 0.7 https://novapharmanews.com/eu/news/european-biotechs-cell-gene-therapy-manufacturing 2026-06-03T04:56:44.221Z weekly 0.7 https://novapharmanews.com/eu/news/eu-lawmakers-critical-medicines-act-deal 2026-06-03T04:56:42.215Z weekly 0.7 https://novapharmanews.com/apac/news/crinetics-pharmaceuticals-jefferies-global-healthcare-2026 2026-06-03T04:56:40.197Z weekly 0.7 https://novapharmanews.com/us/news/krystal-biotech-q1-earnings-beat-catalysts-2026-2027 2026-06-03T04:56:38.217Z weekly 0.7 https://novapharmanews.com/us/news/fda-approves-17-drugs-continuous-manufacturing 2026-06-03T04:56:36.189Z weekly 0.7 https://novapharmanews.com/us/news/rfk-jr-drug-approval-speed-oncology 2026-06-03T04:56:34.189Z weekly 0.7 https://novapharmanews.com/apac/news/clinical-trials-day-2026-research-rising-oncology 2026-06-03T04:56:32.195Z weekly 0.7 https://novapharmanews.com/us/news/fda-in-flux-may-2026-drug-approvals-update 2026-06-03T05:22:54.606Z weekly 0.7 https://novapharmanews.com/apac/news/ildong-pharmaceutical-stock-earnings-pipeline-insights 2026-06-03T04:57:12.212Z weekly 0.7 https://novapharmanews.com/eu/news/teva-olan-ema-acceptance 2026-06-03T04:57:08.222Z weekly 0.7 https://novapharmanews.com/eu/news/mhra-consultation-rare-disease-therapy 2026-06-03T04:57:04.226Z weekly 0.7 https://novapharmanews.com/us/news/fda-fast-track-oncology-drugs-april-2026 2026-06-03T04:57:02.366Z weekly 0.7 https://novapharmanews.com/us/news/fda-guidance-animal-testing-alternatives-concerns 2026-06-03T04:57:02.221Z weekly 0.7 https://novapharmanews.com/us/news/aptar-pharma-fda-research-contract-progress 2026-06-03T04:57:00.219Z weekly 0.7 https://novapharmanews.com/us/news/best-cancer-stocks-2026-investment 2026-06-03T04:56:56.225Z weekly 0.7 https://novapharmanews.com/apac/news/kelun-merck-lung-cancer-combo-china-trial 2026-06-03T04:56:54.231Z weekly 0.7 https://novapharmanews.com/eu/news/serb-pharma-acquires-idefirix-rights 2026-06-03T04:56:52.219Z weekly 0.7 https://novapharmanews.com/us/news/liminatus-acquires-innocsai-320m-car-t-bet 2026-06-03T04:56:48.221Z weekly 0.7 https://novapharmanews.com/eu/news/first-glp-1-gene-therapy-clinical-trial-europe 2026-06-03T04:57:14.230Z weekly 0.7 https://novapharmanews.com/us/news/biomarin-swot-analysis-rare-disease-biotech 2026-06-03T04:57:12.247Z weekly 0.7 https://novapharmanews.com/us/news/new-fda-guidance-ends-nicotine-pouches 2026-06-03T04:57:10.241Z weekly 0.7 https://novapharmanews.com/us/news/2026-pharma-ma-breakout-year 2026-06-03T04:57:26.255Z weekly 0.7 https://novapharmanews.com/us/news/migraine-drugmaker-reverse-merger-market-analysis 2026-06-03T04:57:24.246Z weekly 0.7 https://novapharmanews.com/us/news/regeneron-pharma-stock-institutional-buying-insights 2026-06-03T04:57:22.239Z weekly 0.7 https://novapharmanews.com/us/news/takeda-novartis-layoffs-pharma-impact 2026-06-03T04:57:20.261Z weekly 0.7 https://novapharmanews.com/us/news/fda-lifting-restrictions-compounded-peptides 2026-06-03T04:57:18.239Z weekly 0.7 https://novapharmanews.com/us/news/fda-alert-pulmonology-drug-approvals 2026-06-03T04:57:16.241Z weekly 0.7 https://novapharmanews.com/eu/news/february-batch-novel-medicines-ema-chmp-approval 2026-06-03T04:57:36.351Z weekly 0.7 https://novapharmanews.com/apac/news/zte-partners-china-national-clinical-research-center 2026-06-03T04:57:34.258Z weekly 0.7 https://novapharmanews.com/apac/news/kissei-pharmaceutical-halts-tavneos-use-amid-deaths 2026-06-03T04:57:32.261Z weekly 0.7 https://novapharmanews.com/eu/news/florian-lordick-esmo-president-2026-elections-open 2026-06-03T04:57:30.250Z weekly 0.7 https://novapharmanews.com/apac/news/novartis-pluvicto-stronger-psa-responses-prostate-cancer 2026-06-03T04:57:28.539Z weekly 0.7 https://novapharmanews.com/eu/news/isct-2026-annual-recap 2026-06-03T04:57:44.288Z weekly 0.7 https://novapharmanews.com/us/news/oct-east-coast-2026-recap 2026-06-03T04:57:42.268Z weekly 0.7 https://novapharmanews.com/us/news/fierce-biotech-week-2026-recap 2026-06-03T04:57:40.256Z weekly 0.7 https://novapharmanews.com/us/news/thma-cpe-circle-2026-recap 2026-06-03T04:57:38.255Z weekly 0.7 https://novapharmanews.com/us/news/fda-bayesian-methodology-drug-development 2026-06-03T04:57:50.286Z weekly 0.7 https://novapharmanews.com/eu/news/global-pharmacovigilance-reporting-comparative-analysis 2026-06-03T04:57:48.282Z weekly 0.7 https://novapharmanews.com/us/news/sellas-nears-key-aml-data-dual-trials 2026-06-03T04:57:46.280Z weekly 0.7 https://novapharmanews.com/eu/news/cma-deal-eu-medicine-supply-chains-analysis 2026-06-03T04:57:54.280Z weekly 0.7 https://novapharmanews.com/apac/news/asia-pacific-regulatory-updates-tga-guidance 2026-06-03T04:57:52.276Z weekly 0.7 https://novapharmanews.com/eu/news/x4-pharmaceuticals-ema-chmp-mavorixafor-approval 2026-06-03T05:03:43.817Z weekly 0.7 https://novapharmanews.com/apac/news/shanghai-fosun-pharmaceutical-fda-trial-nod 2026-06-03T04:58:06.304Z weekly 0.7 https://novapharmanews.com/eu/news/future-european-medicine-clinical-research 2026-06-03T04:58:04.293Z weekly 0.7 https://novapharmanews.com/apac/news/risen-pharma-phase-2-trial-rp902-alzheimers 2026-06-03T04:58:02.296Z weekly 0.7 https://novapharmanews.com/eu/news/europes-drug-innovation-edge-risk-dutch-industry-group 2026-06-03T04:58:00.285Z weekly 0.7 https://novapharmanews.com/us/news/layoff-tracker-takeda-novartis-restructuring 2026-06-03T04:57:58.287Z weekly 0.7 https://novapharmanews.com/us/news/top-10-biopharma-ma-deals-2025 2026-06-03T04:57:56.286Z weekly 0.7 https://novapharmanews.com/eu/news/breast-cancer-experts-esmo-2026-abstracts-preview 2026-06-03T04:58:12.311Z weekly 0.7 https://novapharmanews.com/apac/news/fierce-pharma-asia-bms-hengrui-deal-takeda-layoffs 2026-06-03T04:58:11.959Z weekly 0.7 https://novapharmanews.com/us/news/fda-approves-atezolizumab-muscle-invasive-bladder-cancer 2026-06-03T04:58:26.472Z weekly 0.7 https://novapharmanews.com/us/news/ma-in-pharmaceuticals-market-analysis 2026-06-03T04:58:26.309Z weekly 0.7 https://novapharmanews.com/eu/news/q1-2026-life-sciences-law-update-clinical-trials 2026-06-03T04:58:24.312Z weekly 0.7 https://novapharmanews.com/apac/news/global-pharmacovigilance-reporting-regulatory-updates 2026-06-03T04:58:22.410Z weekly 0.7 https://novapharmanews.com/apac/news/kissei-pharmaceutical-halt-tavneos-use-deaths 2026-06-03T04:58:18.295Z weekly 0.7 https://novapharmanews.com/us/news/layoff-tracker-takeda-novartis-restructure 2026-06-03T04:58:16.291Z weekly 0.7 https://novapharmanews.com/us/news/dare-bioscience-phase-2-study-dare-hpv 2026-06-03T04:58:14.292Z weekly 0.7 https://novapharmanews.com/us/news/ucb-acquires-antibody-treatment-maker-autoimmune-disease 2026-06-03T04:58:38.317Z weekly 0.7 https://novapharmanews.com/apac/news/india-cdsco-prior-intimation-system-clinical-trials 2026-06-03T04:58:36.327Z weekly 0.7 https://novapharmanews.com/us/news/big-pharma-ma-mega-year-patent-expiries 2026-06-03T04:58:35.827Z weekly 0.7 https://novapharmanews.com/eu/news/regulatory-round-up-may-11-2026 2026-06-03T04:58:34.386Z weekly 0.7 https://novapharmanews.com/eu/news/ema-critical-medicines-act-market-analysis 2026-06-03T04:58:32.326Z weekly 0.7 https://novapharmanews.com/apac/news/asia-bacitracin-ointment-market-analysis-regulatory-updates 2026-06-03T04:58:28.318Z weekly 0.7 https://novapharmanews.com/us/news/fda-leadership-changes-crisis-drug-approvals 2026-06-03T04:58:54.342Z weekly 0.7 https://novapharmanews.com/eu/news/eu-commission-advances-critical-medicines-act 2026-06-03T04:58:52.347Z weekly 0.7 https://novapharmanews.com/apac/news/the-week-in-pharma-action-reaction-insight-may-15-2026 2026-06-03T04:58:50.343Z weekly 0.7 https://novapharmanews.com/us/news/regulatory-round-up-fda-cancer-drug-approvals 2026-06-03T04:58:48.330Z weekly 0.7 https://novapharmanews.com/eu/news/x4-pharmaceuticals-ema-chmp-positive-opinion-mavorixafor 2026-06-03T04:58:46.327Z weekly 0.7 https://novapharmanews.com/us/news/pharma-ma-roundup-april-2026 2026-06-03T04:58:44.333Z weekly 0.7 https://novapharmanews.com/us/news/10-clinical-trials-to-watch-2026 2026-06-03T04:58:42.321Z weekly 0.7 https://novapharmanews.com/eu/news/europes-biotech-dilemma-discovery-scale-clinical-trials 2026-06-03T04:58:40.327Z weekly 0.7 https://novapharmanews.com/us/news/bio-it-world-conference-2026-recap 2026-06-03T04:58:56.335Z weekly 0.7 https://novapharmanews.com/us/news/makary-resigns-fda-commissioner-drug-approvals 2026-06-03T04:59:00.335Z weekly 0.7 https://novapharmanews.com/us/news/fda-approvals-cancer-drugs-may-2026 2026-06-03T04:58:58.340Z weekly 0.7 https://novapharmanews.com/us/news/6-biotechs-next-ma-target 2026-06-03T04:59:22.375Z weekly 0.7 https://novapharmanews.com/us/news/amgen-inc-stock-lung-cancer-setback-steady-cash-flow 2026-06-03T04:59:20.364Z weekly 0.7 https://novapharmanews.com/us/news/four-fda-actions-reshaping-drug-development-2026 2026-06-03T04:59:18.360Z weekly 0.7 https://novapharmanews.com/eu/news/esmo-updates-ovarian-cancer-guidelines 2026-06-03T04:59:16.357Z weekly 0.7 https://novapharmanews.com/us/news/fda-blocks-melanoma-drug-confusion-makary 2026-06-03T04:59:14.367Z weekly 0.7 https://novapharmanews.com/eu/news/countries-compete-reform-trials-global-sponsors 2026-06-03T04:59:12.352Z weekly 0.7 https://novapharmanews.com/us/news/fda-policy-tracker-2026-psychedelics-regulatory-updates 2026-06-03T04:59:11.491Z weekly 0.7 https://novapharmanews.com/us/news/fda-dual-approval-tdxd-her2-early-breast-cancer 2026-06-03T04:59:10.356Z weekly 0.7 https://novapharmanews.com/us/news/biogen-acquires-apellis-pharmaceuticals-market-analysis 2026-06-03T04:59:08.362Z weekly 0.7 https://novapharmanews.com/eu/news/latest-new-meds-ema-chmp-approval 2026-06-03T04:59:06.348Z weekly 0.7 https://novapharmanews.com/us/news/fda-oncology-drug-approvals-2026 2026-06-03T04:59:02.339Z weekly 0.7 https://novapharmanews.com/apac/news/fierce-pharma-asia-bms-hengrui-takeda-daiichi 2026-06-03T04:59:32.372Z weekly 0.7 https://novapharmanews.com/apac/news/zolbetuximab-phase-2-trial-gastric-cancer 2026-06-03T04:59:30.376Z weekly 0.7 https://novapharmanews.com/eu/news/20-posts-not-to-miss-esmo-breast-cancer-congress-2026 2026-06-03T04:59:28.363Z weekly 0.7 https://novapharmanews.com/eu/news/crinetics-palsonify-sales-enrollment-updates 2026-06-03T04:59:26.368Z weekly 0.7 https://novapharmanews.com/eu/news/european-navenibart-deal-biocryst-analysis 2026-06-03T04:59:24.361Z weekly 0.7 https://novapharmanews.com/us/news/novel-drug-approvals-2026-fda 2026-06-03T04:59:34.378Z weekly 0.7 https://novapharmanews.com/us/news/bbsw-ai-solution-event-daily-roundup 2026-06-03T04:59:36.394Z weekly 0.7 https://novapharmanews.com/us/news/bbsw-ai-solution-event-biotech-innovation-us 2026-06-03T04:59:38.381Z weekly 0.7 https://novapharmanews.com/us/news/bbsw-ai-solution-debuts-for-pharma-insights 2026-06-03T04:59:40.390Z weekly 0.7 https://novapharmanews.com/us/news/dia-2024-regulatory-preview 2026-06-03T04:59:42.393Z weekly 0.7 https://novapharmanews.com/us/news/dia-2024-regulatory-affairs-preview 2026-06-03T04:59:44.390Z weekly 0.7 https://novapharmanews.com/us/news/dia-2024-event-preview 2026-06-03T04:59:53.907Z weekly 0.7 https://novapharmanews.com/us/news/dia-2024-regulatory-conference-preview 2026-06-03T04:59:48.399Z weekly 0.7 https://novapharmanews.com/us/news/bio-it-world-conference-oncology-day-1 2026-06-03T04:59:50.398Z weekly 0.7 https://novapharmanews.com/us/news/biomed-israel-2024-highlights-us 2026-06-03T04:59:52.407Z weekly 0.7 https://novapharmanews.com/us/news/fierce-biotech-week-highlights-trends 2026-06-03T04:59:54.394Z weekly 0.7 https://novapharmanews.com/us/news/scope-x-2026-day-1-roundup 2026-06-03T04:59:56.411Z weekly 0.7 https://novapharmanews.com/us/news/bbsw-ai-solution-biotech-research-us 2026-06-03T04:59:58.406Z weekly 0.7 https://novapharmanews.com/us/news/biomed-israel-2026-highlights-us-implications 2026-06-03T05:00:00.413Z weekly 0.7 https://novapharmanews.com/us/news/biomed-israel-daily-highlights 2026-06-03T05:00:02.413Z weekly 0.7 https://novapharmanews.com/us/news/asgct-2024-gene-therapy-advances 2026-06-03T05:16:00.641Z weekly 0.7 https://novapharmanews.com/us/news/oct-east-coast-daily-roundup 2026-06-03T05:00:06.419Z weekly 0.7 https://novapharmanews.com/us/news/ispor-2026-cardiology-highlights 2026-06-03T05:00:08.419Z weekly 0.7 https://novapharmanews.com/us/news/us-japan-healthcare-conf-2026-highlights 2026-06-03T05:00:10.420Z weekly 0.7 https://novapharmanews.com/us/news/cog-2024-highlights-trends 2026-06-03T05:00:12.436Z weekly 0.7 https://novapharmanews.com/apac/news/pda-manufacturing-apac-highlights 2026-06-03T05:00:14.428Z weekly 0.7 https://novapharmanews.com/us/news/bionj-biopartnering-conference-highlights 2026-06-03T05:00:21.663Z weekly 0.7 https://novapharmanews.com/us/news/asgct-manufacturing-innovations-day1 2026-06-03T05:00:18.425Z weekly 0.7 https://novapharmanews.com/us/news/asgct-2024-gene-therapy-advancements-day-1-roundup 2026-06-03T05:00:20.432Z weekly 0.7 https://novapharmanews.com/us/news/novo-nordisk-record-q1-revenue-wegovy-ozempic 2026-06-03T05:00:22.433Z weekly 0.7 https://novapharmanews.com/us/news/ispor-2026-cardiology-cost-effectiveness 2026-06-03T05:00:25.969Z weekly 0.7 https://novapharmanews.com/apac/news/pda-apac-manufacturing-innovations-day-1-roundup 2026-06-03T05:00:26.441Z weekly 0.7 https://novapharmanews.com/eu/news/isct-2026-eu-manufacturing-day-1 2026-06-03T05:00:34.867Z weekly 0.7 https://novapharmanews.com/us/news/asgct-2024-day-1-gene-therapy-advancements 2026-06-03T05:00:30.442Z weekly 0.7 https://novapharmanews.com/us/news/oct-east-coast-day-1-roundup 2026-06-03T05:13:12.660Z weekly 0.7 https://novapharmanews.com/us/news/biomed-israel-2026-day1-us-biotech-trends 2026-06-03T05:14:36.029Z weekly 0.7 https://novapharmanews.com/us/news/bionj-biopartnering-conference-biotech-innovation 2026-06-03T05:00:36.442Z weekly 0.7 https://novapharmanews.com/us/news/biomed-israel-2026-us-biotech-investors 2026-06-03T05:00:38.461Z weekly 0.7 https://novapharmanews.com/us/news/asgct-2026-gene-therapy-manufacturing-innovations 2026-06-03T05:02:47.745Z weekly 0.7 https://novapharmanews.com/us/news/us-japan-healthcare-conf-2026-day1-roundup 2026-06-03T05:00:42.462Z weekly 0.7 https://novapharmanews.com/us/news/bionj-biopartnering-conference-day-1-highlights 2026-06-03T05:00:48.739Z weekly 0.7 https://novapharmanews.com/us/news/biomed-israel-day-1-biotech-innovation 2026-06-03T05:00:46.459Z weekly 0.7 https://novapharmanews.com/apac/news/pda-apac-pharma-manufacturing-day-1-roundup 2026-06-03T05:00:53.150Z weekly 0.7 https://novapharmanews.com/us/news/us-japan-healthcare-2026-day1-policy-tech 2026-06-03T05:00:51.269Z weekly 0.7 https://novapharmanews.com/us/news/ispor-2026-cardiology-day-1-roundup 2026-06-03T05:00:52.458Z weekly 0.7 https://novapharmanews.com/us/news/fierce-biotech-week-innovations-trends 2026-06-03T05:00:54.457Z weekly 0.7 https://novapharmanews.com/us/news/biomed-israel-daily-roundup 2026-06-03T05:00:56.466Z weekly 0.7 https://novapharmanews.com/apac/news/pda-apac-manufacturing-innovations-day1 2026-06-03T05:00:58.469Z weekly 0.7 https://novapharmanews.com/us/news/us-japan-healthcare-2026-day1-highlights 2026-06-03T05:01:01.960Z weekly 0.7 https://novapharmanews.com/us/news/biomed-israel-2026-us-investor-roundup 2026-06-03T05:01:02.483Z weekly 0.7 https://novapharmanews.com/us/news/asgct-cell-therapy-manufacturing-innovations 2026-06-03T05:01:04.480Z weekly 0.7 https://novapharmanews.com/apac/news/pda-apac-manufacturing-day-1-roundup 2026-06-03T05:01:06.463Z weekly 0.7 https://novapharmanews.com/us/news/us-japan-healthcare-2026-day-1-roundup 2026-06-03T05:01:08.475Z weekly 0.7 https://novapharmanews.com/us/news/ispor-2026-cardiology-day1-roundup 2026-06-03T05:01:10.475Z weekly 0.7 https://novapharmanews.com/us/news/biomed-israel-2026-us-investors 2026-06-03T05:01:12.471Z weekly 0.7 https://novapharmanews.com/us/news/biomed-israel-day-1-highlights 2026-06-03T05:01:14.565Z weekly 0.7 https://novapharmanews.com/us/news/fierce-biotech-week-daily-roundup 2026-06-03T05:01:16.479Z weekly 0.7 https://novapharmanews.com/us/news/bionj-biopartnering-conference-day-1 2026-06-03T05:01:18.481Z weekly 0.7 https://novapharmanews.com/us/news/asgct-2026-manufacturing-day-1-roundup 2026-06-03T05:01:27.062Z weekly 0.7 https://novapharmanews.com/us/news/biomed-israel-2026-us-biotech-roundup 2026-06-03T05:01:22.488Z weekly 0.7 https://novapharmanews.com/us/news/asgct-2024-gene-therapy-advancements-day-1 2026-06-03T05:01:24.542Z weekly 0.7 https://novapharmanews.com/us/news/thma-cpe-circle-highlights-key-trends 2026-06-03T05:01:26.499Z weekly 0.7 https://novapharmanews.com/us/news/excipient-world-conference-highlights 2026-06-03T05:01:28.494Z weekly 0.7 https://novapharmanews.com/eu/news/raps-euro-convergence-regulatory-highlights 2026-06-03T05:01:30.499Z weekly 0.7 https://novapharmanews.com/us/news/asgct-cell-gene-therapy-manufacturing-innovations 2026-06-03T05:01:32.501Z weekly 0.7 https://novapharmanews.com/apac/news/apac-clinical-event-preview 2026-06-03T05:01:34.507Z weekly 0.7 https://novapharmanews.com/eu/news/isct-2026-eu-manufacturing-day-1-roundup 2026-06-03T05:01:36.509Z weekly 0.7 https://novapharmanews.com/us/news/asgct-manufacturing-innovations 2026-06-03T05:01:38.504Z weekly 0.7 https://novapharmanews.com/us/news/thma-cpe-circle-daily-roundup 2026-06-03T05:01:40.525Z weekly 0.7 https://novapharmanews.com/us/news/asgct-2024-gene-therapy-advancements 2026-06-03T05:01:42.516Z weekly 0.7 https://novapharmanews.com/us/news/thma-oncology-forum-highlights-us 2026-06-03T05:01:48.995Z weekly 0.7 https://novapharmanews.com/us/news/fdli-2026-annual-highlights 2026-06-03T05:01:46.516Z weekly 0.7 https://novapharmanews.com/eu/news/raps-euro-convergence-regulatory-insights 2026-06-03T05:01:48.524Z weekly 0.7 https://novapharmanews.com/us/news/aphl-2026-highlights-innovations 2026-06-03T05:01:53.621Z weekly 0.7 https://novapharmanews.com/us/news/fdli-annual-2026-regulatory-insights 2026-06-03T05:05:05.326Z weekly 0.7 https://novapharmanews.com/us/news/APHL-2026-annual-day-1-roundup 2026-06-03T05:01:54.550Z weekly 0.7 https://novapharmanews.com/us/news/aphl-2026-annual-day-1-highlights 2026-06-03T05:01:56.529Z weekly 0.7 https://novapharmanews.com/us/news/thma-oncology-forum-daily-roundup 2026-06-03T05:01:58.524Z weekly 0.7 https://novapharmanews.com/eu/news/european-research-revolution-key-takeaways 2026-06-03T05:02:06.843Z weekly 0.7 https://novapharmanews.com/us/news/ipec-annual-meeting-highlights-us 2026-06-03T05:02:02.535Z weekly 0.7 https://novapharmanews.com/eu/news/raps-euro-convergence-regulatory-updates 2026-06-03T05:02:04.543Z weekly 0.7 https://novapharmanews.com/us/news/fdli-annual-2026-daily-roundup 2026-06-03T05:02:13.073Z weekly 0.7 https://novapharmanews.com/us/news/thma-oncology-forum-day1-roundup 2026-06-03T05:02:08.538Z weekly 0.7 https://novapharmanews.com/us/news/fdli-annual-2026-regulatory-insights-policy-updates 2026-06-03T05:02:10.553Z weekly 0.7 https://novapharmanews.com/us/news/thma-oncology-forum-day-1-roundup 2026-06-03T05:02:12.546Z weekly 0.7 https://novapharmanews.com/us/news/fdli-annual-2026-regulatory-updates 2026-06-03T05:02:14.548Z weekly 0.7 https://novapharmanews.com/eu/news/raps-euro-convergence-day-1-regulatory-updates 2026-06-03T05:02:22.632Z weekly 0.7 https://novapharmanews.com/eu/news/swiss-biotech-day-key-innovations-partnerships 2026-06-03T05:02:18.555Z weekly 0.7 https://novapharmanews.com/eu/news/european-research-revolution-day-1 2026-06-03T05:02:20.559Z weekly 0.7 https://novapharmanews.com/eu/news/raps-euro-convergence-regulatory-insights-day-1 2026-06-03T05:02:22.555Z weekly 0.7 https://novapharmanews.com/eu/news/european-research-revolution-day-1-highlights 2026-06-03T05:02:24.566Z weekly 0.7 https://novapharmanews.com/eu/news/raps-euro-convergence-regulatory-updates-day-1 2026-06-03T05:02:26.557Z weekly 0.7 https://novapharmanews.com/apac/news/cryoport-q1-2026-financial-results-clinical-trials-cell-gene-therapy 2026-06-03T05:02:31.706Z weekly 0.7 https://novapharmanews.com/apac/news/ascidian-acdn-01-stellar-trial-stargardt-disease-dose-escalation-complete 2026-06-03T05:02:34.356Z weekly 0.7 https://novapharmanews.com/apac/news/quiver-bioscience-nih-heal-grant-qv-2421-chronic-pain-trials 2026-06-03T05:02:36.099Z weekly 0.7 https://novapharmanews.com/apac/news/lunai-bioworks-20-million-cns-drug-delivery-alzheimer-treatment 2026-06-03T05:02:34.564Z weekly 0.7 https://novapharmanews.com/apac/news/stryker-australia-tga-approval-temporomandibular-joint-prosthesis 2026-06-03T05:02:36.571Z weekly 0.7 https://novapharmanews.com/apac/news/tga-section-41hd-medical-device-emergency-import-approvals-australia 2026-06-03T05:02:38.569Z weekly 0.7 https://novapharmanews.com/eu/news/biotheryx-btx-9341-phase-1a-results-esmo-breast-cancer-congress-2026 2026-06-03T05:02:48.856Z weekly 0.7 https://novapharmanews.com/us/news/palvella-qtorin-rapamycin-phase-2-trial-angiokeratomas 2026-06-03T05:02:42.666Z weekly 0.7 https://novapharmanews.com/us/news/neurocrine-biosciences-nbip-2118-phase-1-obesity-trial 2026-06-03T05:02:51.292Z weekly 0.7 https://novapharmanews.com/us/news/caplyta-lumateperone-tops-adjunctive-depression-treatments-meta-analysis 2026-06-03T05:02:46.595Z weekly 0.7 https://novapharmanews.com/us/news/cellenkos-fda-clearance-ck0802-phase-2a-trial-steroid-refractory-gvhd 2026-06-03T05:02:50.308Z weekly 0.7 https://novapharmanews.com/us/news/cellenkos-fda-clearance-ck0802-phase-1b-2a-trial-steroid-refractory-gvhd 2026-06-03T05:02:50.582Z weekly 0.7 https://novapharmanews.com/us/news/fda-approves-guardant360-cdx-veppanu-breast-cancer-diagnostic 2026-06-03T05:02:52.606Z weekly 0.7 https://novapharmanews.com/us/news/opus-genetics-opgx-lca5-fda-rare-disease-evidence-program 2026-06-03T05:02:54.606Z weekly 0.7 https://novapharmanews.com/eu/news/raps-euro-convergence-2026-day-1-roundup 2026-06-03T05:02:56.596Z weekly 0.7 https://novapharmanews.com/eu/news/heart-failure-2026-vutrisiran-data-european-pharma-news 2026-06-03T05:02:58.597Z weekly 0.7 https://novapharmanews.com/apac/news/telix-tlx250-px-zircaix-kidney-cancer-diagnosis-phase-3-zircon 2026-06-03T05:03:06.377Z weekly 0.7 https://novapharmanews.com/apac/news/arrowhead-pharmaceuticals-redemplo-plozasiran-tga-approval-australia-fcs 2026-06-03T05:03:02.615Z weekly 0.7 https://novapharmanews.com/apac/news/mifepristone-access-supreme-court-hold-planned-parenthood-5th-circuit 2026-06-03T05:03:04.613Z weekly 0.7 https://novapharmanews.com/eu/news/cvrx-benefit-hf-trial-barostim-heart-failure-first-patient 2026-06-03T05:03:06.697Z weekly 0.7 https://novapharmanews.com/eu/news/agenus-q1-2026-financial-report-botensilimab-balstilimab-update 2026-06-03T05:03:15.782Z weekly 0.7 https://novapharmanews.com/eu/news/oncolytics-biotech-pelareorep-colorectal-cancer-durable-responses 2026-06-03T05:03:10.621Z weekly 0.7 https://novapharmanews.com/eu/news/crispr-therapeutics-q1-2026-casgevy-global-approval 2026-06-03T05:33:24.050Z weekly 0.7 https://novapharmanews.com/us/news/clene-cnm-au8-fda-accelerated-approval-als-treatment-2024 2026-06-03T05:03:14.633Z weekly 0.7 https://novapharmanews.com/us/news/alpha-tau-alpha-dart-100-percent-disease-control-pancreatic-cancer-ddw-2026 2026-06-03T05:03:16.664Z weekly 0.7 https://novapharmanews.com/us/news/takeda-tak-881-positive-phase-2-3-results-primary-immunodeficiency-disease 2026-06-03T05:03:18.631Z weekly 0.7 https://novapharmanews.com/us/news/accord-healthcare-relaunches-tadalafil-tablets-generic-ed-treatment 2026-06-03T05:03:20.621Z weekly 0.7 https://novapharmanews.com/us/news/inspiremd-fda-approval-switchguard-neuro-protection-cguardians-iii-trial 2026-06-03T05:03:22.629Z weekly 0.7 https://novapharmanews.com/apac/news/xtalpi-pep08-prmt5-inhibitor-phase-1-cancer-trial-enrollment 2026-06-03T05:03:24.627Z weekly 0.7 https://novapharmanews.com/apac/news/spontan-phase-ii-data-10-minute-onset-fda-requirements-erectile-dysfunction 2026-06-03T05:03:26.633Z weekly 0.7 https://novapharmanews.com/apac/news/ironwood-pharmaceuticals-short-bowel-syndrome-tpn-survey-ddw-2026 2026-06-03T05:03:28.638Z weekly 0.7 https://novapharmanews.com/apac/news/edwards-lifesciences-resilia-tissue-10-year-commence-trial-results 2026-06-03T05:03:30.638Z weekly 0.7 https://novapharmanews.com/apac/news/novo-nordisk-wegovy-china-launch-eli-lilly-obesity-market 2026-06-03T05:03:32.639Z weekly 0.7 https://novapharmanews.com/apac/news/arrowhead-pharmaceuticals-tga-approval-redemplo-plozasiran-australia-fcs 2026-06-03T05:03:38.897Z weekly 0.7 https://novapharmanews.com/apac/news/biomarin-palynziq-fda-approval-adolescent-pku-patients 2026-06-03T05:03:36.654Z weekly 0.7 https://novapharmanews.com/apac/news/rois-us-expansion-global-cdmo-fda-approval-injectable-manufacturing 2026-06-03T05:03:38.663Z weekly 0.7 https://novapharmanews.com/apac/news/fda-approves-travere-filspari-fsgs-treatment-adults-children 2026-06-03T05:03:41.051Z weekly 0.7 https://novapharmanews.com/eu/news/vanda-pharmaceuticals-nereus-tradipitant-motion-sickness-drug-launch 2026-06-03T05:03:42.667Z weekly 0.7 https://novapharmanews.com/eu/news/takeda-tak-881-phase-3-trial-primary-immunodeficiency-disease-results 2026-06-03T05:03:44.661Z weekly 0.7 https://novapharmanews.com/eu/news/pulse-biosciences-atrial-fibrillation-treatment-100-percent-success-rate-2026 2026-06-03T05:03:46.673Z weekly 0.7 https://novapharmanews.com/eu/news/sq-innovation-lasix-onyu-subcut-hf-ii-trial-results-heart-failure-2026 2026-06-03T05:03:48.660Z weekly 0.7 https://novapharmanews.com/eu/news/krystal-biotech-q1-2026-results-vyjuvek-expansion-registrational-studies 2026-06-03T05:03:50.674Z weekly 0.7 https://novapharmanews.com/eu/news/acurx-dna-pol-iiic-inhibitors-microbiome-preservation-mrsa-escmid-2026 2026-06-03T05:20:56.429Z weekly 0.7 https://novapharmanews.com/eu/news/biocryst-navenibart-european-licensing-deal-neopharmed-gentili 2026-06-03T05:03:54.665Z weekly 0.7 https://novapharmanews.com/eu/news/biosimulation-market-11-billion-2031-drug-development 2026-06-03T05:03:56.670Z weekly 0.7 https://novapharmanews.com/eu/news/grin-therapeutics-phase-3-beeline-study-radiprodil-europe-grin-ndd 2026-06-03T05:03:58.675Z weekly 0.7 https://novapharmanews.com/eu/news/fda-approves-langlara-biosimilar-lantus-insulin-lannett-company 2026-06-03T05:04:00.675Z weekly 0.7 https://novapharmanews.com/eu/news/vertex-casgevy-gene-therapy-global-expansion-q1-2026-results 2026-06-03T05:04:02.689Z weekly 0.7 https://novapharmanews.com/eu/news/oncolytics-biotech-pelareorep-durable-responses-ras-mutant-colorectal-cancer 2026-06-03T05:04:04.687Z weekly 0.7 https://novapharmanews.com/eu/news/nuvation-bio-ibtrozi-q1-2026-revenue-ros1-nsclc 2026-06-03T05:17:07.195Z weekly 0.7 https://novapharmanews.com/us/news/crispr-therapeutics-casgevy-global-approvals-60000-patients 2026-06-03T05:04:08.678Z weekly 0.7 https://novapharmanews.com/us/news/clene-cnm-au8-fda-accelerated-approval-pathway-als-treatment 2026-06-03T05:04:10.693Z weekly 0.7 https://novapharmanews.com/us/news/atossa-therapeutics-fda-rare-pediatric-disease-designation-z-endoxifen-mccune-albright-syndrome 2026-06-03T05:04:12.694Z weekly 0.7 https://novapharmanews.com/us/news/mbiota-elemental-ibs-treatment-ddw-2026-clinical-trial 2026-06-03T05:04:14.688Z weekly 0.7 https://novapharmanews.com/us/news/novartis-fabhalta-health-canada-approval-c3g-treatment 2026-06-03T05:04:16.686Z weekly 0.7 https://novapharmanews.com/us/news/asco-2026-cellectar-waldenstrom-macroglobulinemia 2026-06-03T05:04:18.698Z weekly 0.7 https://novapharmanews.com/us/news/alpha-tau-alpha-dart-pancreatic-cancer-trials-ddw-2026 2026-06-03T05:04:20.693Z weekly 0.7 https://novapharmanews.com/us/news/cytokinetics-aficamten-phase-3-trial-results-non-obstructive-hypertrophic-cardiomyopathy-may-2026 2026-06-03T05:04:22.717Z weekly 0.7 https://novapharmanews.com/us/news/inflarx-izicopan-reactive-metabolite-liver-safety-study 2026-06-03T05:04:24.705Z weekly 0.7 https://novapharmanews.com/us/news/macrogenics-expands-zynyz-royalty-agreement-sagard-healthcare 2026-06-03T05:04:27.925Z weekly 0.7 https://novapharmanews.com/us/news/akebia-vadadustat-mortality-reduction-kidney-disease-jasn-study 2026-06-03T05:04:28.813Z weekly 0.7 https://novapharmanews.com/us/news/inflarx-izicopan-favorable-liver-metabolism-safety-profile-2026 2026-06-03T05:04:30.712Z weekly 0.7 https://novapharmanews.com/us/news/celcuity-gedatolisib-phase-3-viktoria-1-trial-pik3ca-mutant-cancer 2026-06-03T05:04:32.716Z weekly 0.7 https://novapharmanews.com/us/news/fda-approves-langlara-interchangeable-biosimilar-lantus-insulin-lannett 2026-06-03T05:04:34.726Z weekly 0.7 https://novapharmanews.com/us/news/fda-approves-guardant360-cdx-companion-diagnostic-pfizer-veppanu-breast-cancer 2026-06-03T05:04:36.716Z weekly 0.7 https://novapharmanews.com/us/news/fda-approves-incyte-jakafi-xr-extended-release-myelofibrosis 2026-06-03T05:04:38.768Z weekly 0.7 https://novapharmanews.com/us/news/arvinas-veppanu-vepdegestrant-fda-approval-first-protac-drug-esr1-breast-cancer 2026-06-03T05:04:40.771Z weekly 0.7 https://novapharmanews.com/us/news/excipient-world-conference-daily-roundup 2026-06-03T05:04:42.753Z weekly 0.7 https://novapharmanews.com/us/news/APHL-2026-annual-meeting-day-1-highlights 2026-06-03T05:04:47.862Z weekly 0.7 https://novapharmanews.com/us/news/aphl-2026-day-1-roundup 2026-06-03T05:04:46.762Z weekly 0.7 https://novapharmanews.com/eu/news/swiss-biotech-day-daily-roundup 2026-06-03T05:04:48.764Z weekly 0.7 https://novapharmanews.com/apac/news/fda-approves-auvelity-new-mdd-treatment 2026-06-03T05:04:50.773Z weekly 0.7 https://novapharmanews.com/apac/news/sun-pharma-organon-partnership-india 2026-06-03T05:04:52.778Z weekly 0.7 https://novapharmanews.com/eu/news/fda-approves-auvelity-mdd-axsome-therapeutics 2026-06-03T05:04:54.770Z weekly 0.7 https://novapharmanews.com/eu/news/purdue-pharma-shutdown-oxycontin-settlement 2026-06-03T05:04:58.847Z weekly 0.7 https://novapharmanews.com/us/news/fda-approves-palazestrant-pfizer-arvinas-breast-cancer-drug 2026-06-03T05:04:58.790Z weekly 0.7 https://novapharmanews.com/eu/news/eular-2026-immutep-imp761-phase-1-preview 2026-06-03T05:05:00.784Z monthly 0.5 https://novapharmanews.com/us/news/thma-pharmacy-growth-priorities-2026 2026-06-03T05:05:02.791Z monthly 0.5 https://novapharmanews.com/us/news/cphi-americas-2026-pharma-manufacturing-trends 2026-06-03T05:05:04.796Z monthly 0.5 https://novapharmanews.com/us/news/ipec-americas-annual-meeting-daily-roundup 2026-06-03T05:05:06.788Z monthly 0.5 https://novapharmanews.com/us/news/excipient-world-conference-day-1-highlights 2026-06-03T05:05:08.779Z monthly 0.5 https://novapharmanews.com/us/news/aphl-2026-annual-day-1-roundup 2026-06-03T05:05:10.782Z monthly 0.5 https://novapharmanews.com/apac/news/ucb-acquires-candid-therapeutics-2-2-billion-t-cell-engager-autoimmune 2026-06-03T05:05:12.783Z monthly 0.5 https://novapharmanews.com/eu/news/novelty-nobility-agc-biologics-bispecific-antibody-manufacturing-partnership 2026-06-03T05:05:18.911Z monthly 0.5 https://novapharmanews.com/eu/news/smartee-denti-technology-mandibular-repositioning-eas-congress-2026 2026-06-03T05:05:16.796Z monthly 0.5 https://novapharmanews.com/us/news/xtalpi-pep08-prmt5-inhibitor-phase-1-cancer-trial-enrollment 2026-06-03T05:05:18.810Z monthly 0.5 https://novapharmanews.com/us/news/mirum-pharmaceuticals-vistas-volixibat-primary-sclerosing-cholangitis-results-may-2026 2026-06-03T05:05:20.799Z monthly 0.5 https://novapharmanews.com/us/news/everads-therapy-suprachoroidal-injector-clinical-data-ophthalmology-science 2026-06-03T05:05:23.176Z monthly 0.5 https://novapharmanews.com/us/news/ucb-acquires-candid-therapeutics-autoimmune-deal 2026-06-03T05:05:24.790Z monthly 0.5 https://novapharmanews.com/us/news/spinogenix-tazbentetol-neuroprotective-glaucoma-diabetic-retinopathy-arvo-2026 2026-06-03T05:05:26.797Z monthly 0.5 https://novapharmanews.com/us/news/niktimvo-axatilimab-approved-australia-chronic-gvhd-treatment 2026-06-03T05:05:30.570Z monthly 0.5 https://novapharmanews.com/us/news/ipec-annual-meeting-2026-no-pharma-news 2026-06-03T05:05:30.797Z monthly 0.5 https://novapharmanews.com/eu/news/swiss-biotech-day-2026-ai-oncology-microbiome 2026-06-03T05:05:38.128Z monthly 0.5 https://novapharmanews.com/us/news/excipient-world-conference-2026-daily-roundup 2026-06-03T05:05:34.809Z monthly 0.5 https://novapharmanews.com/us/news/aphl-2026-annual-meeting-opens-public-health-lab-focus 2026-06-03T05:05:36.809Z monthly 0.5 https://novapharmanews.com/apac/news/fda-approves-auvelity-mdd-new-antidepressant 2026-06-03T05:05:38.807Z monthly 0.5 https://novapharmanews.com/eu/news/purdue-pharma-dissolution-approved-opioid-crisis 2026-06-03T05:05:42.491Z monthly 0.5 https://novapharmanews.com/eu/news/auvelity-fda-approval-axsome-therapeutics 2026-06-03T05:05:42.815Z monthly 0.5 https://novapharmanews.com/us/news/axsome-fda-approval-alzheimers-agitation 2026-06-03T05:05:44.828Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-first-non-antipsychotic-dementia-agitation 2026-06-03T05:05:46.833Z monthly 0.5 https://novapharmanews.com/apac/news/a2-milk-company-recalls-platinum-infant-formula-health-risk 2026-06-03T05:05:48.836Z monthly 0.5 https://novapharmanews.com/us/news/edwards-lifesciences-resilia-tissue-10-year-durability-aortic-valve-trial 2026-06-03T05:05:50.824Z monthly 0.5 https://novapharmanews.com/us/news/biomarin-voxzogo-achondroplasia-long-term-data-pes-2026 2026-06-03T05:05:59.575Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-incyte-jakafi-xr-extended-release-myelofibrosis-polycythemia-vera 2026-06-03T05:05:54.828Z monthly 0.5 https://novapharmanews.com/apac/news/fda-approves-auvelity-axsome-therapeutics-mdd 2026-06-03T05:05:56.839Z monthly 0.5 https://novapharmanews.com/eu/news/fda-approves-auvelity-for-major-depressive-disorder 2026-06-03T05:05:59.752Z monthly 0.5 https://novapharmanews.com/us/news/plozasiran-tga-approval-australia-redemplo-fcs 2026-06-03T05:06:00.839Z monthly 0.5 https://novapharmanews.com/apac/news/vector-science-therapeutics-microneedle-catheter-patent-intratumoral-drug-delivery 2026-06-03T05:06:02.839Z monthly 0.5 https://novapharmanews.com/apac/news/apotex-generic-ozempic-semaglutide-health-canada-approval-2026 2026-06-03T05:06:04.864Z monthly 0.5 https://novapharmanews.com/apac/news/keenova-terlivaz-terlipressin-clinical-data-digestive-disease-week-2026 2026-06-03T05:06:06.844Z monthly 0.5 https://novapharmanews.com/apac/news/kodiak-sciences-ksi-101-clinical-data-macular-edema-conferences 2026-06-03T05:06:08.867Z monthly 0.5 https://novapharmanews.com/eu/news/synbiotech-microbiome-womens-healthy-aging-vitafoods-2026 2026-06-03T05:06:10.859Z monthly 0.5 https://novapharmanews.com/eu/news/curaleaf-torsten-greif-board-appointment-european-cannabis 2026-06-03T05:06:12.854Z monthly 0.5 https://novapharmanews.com/eu/news/pharmaceutical-manufacturing-software-market-787-billion-2030 2026-06-03T05:06:14.863Z monthly 0.5 https://novapharmanews.com/eu/news/goodrx-ozempic-pill-type-2-diabetes-149-monthly 2026-06-03T05:06:16.867Z monthly 0.5 https://novapharmanews.com/us/news/neurocrine-crenessity-two-year-pediatric-cah-study-results 2026-06-03T05:06:18.867Z monthly 0.5 https://novapharmanews.com/us/news/cairn-surgical-breast-cancer-locator-system-pivotal-trial-results 2026-06-03T05:06:20.878Z monthly 0.5 https://novapharmanews.com/us/news/restore-vision-rv-001-gene-therapy-retinitis-pigmentosa-clinical-results 2026-06-03T05:06:22.952Z monthly 0.5 https://novapharmanews.com/us/news/archimed-acquires-esperion-therapeutics-cardiometabolic-deal-2026 2026-06-03T05:06:24.864Z monthly 0.5 https://novapharmanews.com/us/news/oculis-dme-research-arvo-2026-presentation 2026-06-03T05:06:26.868Z monthly 0.5 https://novapharmanews.com/us/news/rhythm-pharmaceuticals-imcivree-european-commission-approval-hypothalamic-obesity 2026-06-03T05:06:28.885Z monthly 0.5 https://novapharmanews.com/us/news/atara-biotherapeutics-ebvallo-fda-complete-response-letter-securities-lawsuit 2026-06-03T05:06:30.872Z monthly 0.5 https://novapharmanews.com/us/news/vanda-pharmaceuticals-nereus-tradipitant-motion-sickness-drug-available 2026-06-03T05:06:32.886Z monthly 0.5 https://novapharmanews.com/us/news/novo-nordisk-oral-ozempic-fda-approved-pill-glp1-type-2-diabetes-cardiovascular 2026-06-03T05:06:34.876Z monthly 0.5 https://novapharmanews.com/us/news/zeta-surgical-fda-clearance-brain-surgery-navigation-system 2026-06-03T05:06:36.880Z monthly 0.5 https://novapharmanews.com/us/news/viatris-low-dose-estrogen-contraceptive-patch-acog-2026 2026-06-03T05:06:38.880Z monthly 0.5 https://novapharmanews.com/us/news/axsome-auvelity-fda-approval-alzheimers-agitation-treatment 2026-06-03T05:06:40.886Z monthly 0.5 https://novapharmanews.com/us/news/incyte-jakafi-xr-fda-approval-myelofibrosis-polycythemia-vera-gvhd 2026-06-03T05:06:42.882Z monthly 0.5 https://novapharmanews.com/us/news/arvinas-fda-approval-veppanu-vepdegestrant-protac-esr1-breast-cancer 2026-06-03T05:06:44.890Z monthly 0.5 https://novapharmanews.com/apac/news/plozasiran-tga-approval-australia-redemplo-fcs 2026-06-03T05:06:46.893Z monthly 0.5 https://novapharmanews.com/eu/news/plozasiran-tga-approval-australia-fcs 2026-06-03T05:06:48.890Z monthly 0.5 https://novapharmanews.com/us/news/moderna-fda-talks-phase-4-covid-vaccine-data 2026-06-03T05:06:50.890Z monthly 0.5 https://novapharmanews.com/us/news/the-common-fund-data-ecosystem-cfde-449d7791 2026-06-03T05:06:52.902Z monthly 0.5 https://novapharmanews.com/apac/news/namsa-lexitas-partnership-ophthalmic-medical-device-development 2026-06-03T05:06:58.181Z monthly 0.5 https://novapharmanews.com/apac/news/verified-clinical-trials-chubb-partnership-patient-safety-data-quality 2026-06-03T05:06:56.898Z monthly 0.5 https://novapharmanews.com/apac/news/huahui-health-beone-medicines-hh160-trispecific-antibody-oncology-partnership 2026-06-03T05:06:58.895Z monthly 0.5 https://novapharmanews.com/apac/news/amgen-q1-2026-financial-results-double-digit-growth 2026-06-03T05:07:00.905Z monthly 0.5 https://novapharmanews.com/apac/news/haier-biomedical-international-revenue-growth-2025 2026-06-03T05:07:02.985Z monthly 0.5 https://novapharmanews.com/apac/news/tga-combination-boundary-products-guidance-apac-pharmaceutical 2026-06-03T05:07:04.904Z monthly 0.5 https://novapharmanews.com/apac/news/genprex-israel-patent-reqorsa-gene-therapy-pd1-antibodies-cancer 2026-06-03T05:07:06.994Z monthly 0.5 https://novapharmanews.com/apac/news/prolacta-human-milk-fortifiers-prescription-drug-status-japan-jasmine-trial 2026-06-03T05:07:08.904Z monthly 0.5 https://novapharmanews.com/eu/news/stoke-therapeutics-zorevunersen-dravet-syndrome-q1-2026-results 2026-06-03T05:07:10.913Z monthly 0.5 https://novapharmanews.com/eu/news/uniqure-amt-130-gene-therapy-uk-approval-huntingtons-disease 2026-06-03T05:07:16.370Z monthly 0.5 https://novapharmanews.com/eu/news/northwest-biotherapeutics-annalisa-jenkins-dcvax-cancer-vaccine-adviser 2026-06-03T05:07:15.005Z monthly 0.5 https://novapharmanews.com/eu/news/cerus-intercept-blood-system-european-regulatory-review-phase-3-trials 2026-06-03T05:07:16.925Z monthly 0.5 https://novapharmanews.com/eu/news/bio-rad-q1-2026-ivdr-compliance-costs-european-diagnostics 2026-06-03T05:07:18.917Z monthly 0.5 https://novapharmanews.com/eu/news/fda-advisory-committee-recommends-astrazeneca-truqap-pten-deficient-prostate-cancer 2026-06-03T05:07:20.923Z monthly 0.5 https://novapharmanews.com/eu/news/alkeus-gildeuretinol-stargardt-disease-arvo-2026-data 2026-06-03T05:07:22.932Z monthly 0.5 https://novapharmanews.com/eu/news/setpoint-medical-multiple-sclerosis-trial-neuroimmune-therapy 2026-06-03T05:07:24.919Z monthly 0.5 https://novapharmanews.com/eu/news/emergent-biosolutions-q1-2026-financial-results 2026-06-03T05:07:26.924Z monthly 0.5 https://novapharmanews.com/eu/news/telix-tlx101-px-pixlumi-brain-cancer-imaging-european-approval 2026-06-03T05:07:28.924Z monthly 0.5 https://novapharmanews.com/us/news/mrm-health-mh002-fda-fast-track-ulcerative-colitis 2026-06-03T05:07:30.944Z monthly 0.5 https://novapharmanews.com/us/news/cadrenal-therapeutics-cad-1005-fda-phase-3-heparin-induced-thrombocytopenia 2026-06-03T05:07:32.935Z monthly 0.5 https://novapharmanews.com/us/news/redhill-rhb-204-comparable-efficacy-rhb-104-crohns-disease-map-treatment 2026-06-03T05:07:34.933Z monthly 0.5 https://novapharmanews.com/us/news/phathom-pharmaceuticals-voquezna-q1-2026-earnings-profitability-guidance 2026-06-03T05:07:38.528Z monthly 0.5 https://novapharmanews.com/us/news/contineum-therapeutics-pipe-791-positive-phase-1b-chronic-pain-results 2026-06-03T05:07:38.931Z monthly 0.5 https://novapharmanews.com/us/news/summit-therapeutics-ivonescimab-overall-survival-lung-cancer-asco-2026 2026-06-03T05:08:46.164Z monthly 0.5 https://novapharmanews.com/us/news/ac-immune-aci-24-alzheimers-trial-final-cohort-aci-19764-phase-1 2026-06-03T05:07:43.091Z monthly 0.5 https://novapharmanews.com/us/news/addex-dipraglurant-brain-injury-recovery-2025-results 2026-06-03T05:07:45.072Z monthly 0.5 https://novapharmanews.com/us/news/ac-immune-final-cohort-abate-trial-anti-abeta-alzheimer-treatment 2026-06-03T05:07:47.079Z monthly 0.5 https://novapharmanews.com/us/news/mabwell-9mw2821-cervical-cancer-esmo-gc-2026 2026-06-03T05:07:52.852Z monthly 0.5 https://novapharmanews.com/us/news/aquestive-therapeutics-securities-fraud-lawsuit-anaphylm-fda-review 2026-06-03T05:07:51.066Z monthly 0.5 https://novapharmanews.com/us/news/immunitybio-ibrx-fda-warning-letter-ankt-lawsuit-2026 2026-06-03T05:07:53.080Z monthly 0.5 https://novapharmanews.com/us/news/fda-advisory-committee-recommends-astrazeneca-truqap-pten-deficient-prostate-cancer 2026-06-03T05:07:55.092Z monthly 0.5 https://novapharmanews.com/us/news/eli-lilly-foundayo-orforglipron-fda-approval-obesity-q1-2026-results 2026-06-03T05:07:57.069Z monthly 0.5 https://novapharmanews.com/us/news/theradaptive-fda-approval-osteoadapt-sp-phase-3-spinal-fusion-trial 2026-06-03T05:07:59.099Z monthly 0.5 https://novapharmanews.com/eu/news/eu-biopharma-clinical-trials-ai-gene-therapy 2026-06-03T05:08:02.216Z monthly 0.5 https://novapharmanews.com/us/news/pharma-partnering-us-q1-2026-licensing-deals 2026-06-03T05:30:18.537Z monthly 0.5 https://novapharmanews.com/us/news/fierce-biotech-week-2026-ai-oncology-preview 2026-06-03T05:08:07.913Z monthly 0.5 https://novapharmanews.com/us/news/ipec-excipient-world-biologics-summit-2026-preview 2026-06-03T05:08:07.080Z monthly 0.5 https://novapharmanews.com/apac/news/axoft-55m-series-a-brain-computer-interface-clinical-trials 2026-06-03T05:08:15.695Z monthly 0.5 https://novapharmanews.com/apac/news/vivacta-bio-50-million-series-a-funding-gt801-car-t-therapy 2026-06-03T05:08:11.080Z monthly 0.5 https://novapharmanews.com/apac/news/taimei-technology-ai-clinical-trials-biokorea-2026 2026-06-03T05:08:13.087Z monthly 0.5 https://novapharmanews.com/apac/news/energenesis-energi-f703dfu-diabetic-foot-ulcer-ewma-2026 2026-06-03T05:08:15.083Z monthly 0.5 https://novapharmanews.com/apac/news/ascletis-pharma-diabetes-drug-data-ada-2026-scientific-sessions 2026-06-03T05:08:17.087Z monthly 0.5 https://novapharmanews.com/apac/news/tlx597-tx-psma-radioligand-therapy-optimal-trial-prostate-cancer 2026-06-03T05:08:19.099Z monthly 0.5 https://novapharmanews.com/apac/news/immunitybio-securities-fraud-lawsuit-anktiva-fda-warning-letter 2026-06-03T05:08:21.117Z monthly 0.5 https://novapharmanews.com/eu/news/hutchmed-sovleplenib-priority-review-breakthrough-designation-china-autoimmune-hemolytic-anemia 2026-06-03T05:08:23.099Z monthly 0.5 https://novapharmanews.com/eu/news/fda-real-world-evidence-framework-medtech-ventripoint-10-billion 2026-06-03T05:08:25.100Z monthly 0.5 https://novapharmanews.com/us/news/teva-acquires-emalex-ecopipam-tourette-syndrome-drug-700-million 2026-06-03T05:08:27.113Z monthly 0.5 https://novapharmanews.com/us/news/purespring-therapeutics-nphs2-genetic-variants-adult-onset-fsgs-study 2026-06-03T05:08:29.103Z monthly 0.5 https://novapharmanews.com/us/news/viking-therapeutics-vk2735-phase-3-obesity-trials-enrolled-q1-2026 2026-06-03T05:08:36.905Z monthly 0.5 https://novapharmanews.com/us/news/relay-therapeutics-q1-2026-earnings-zovegalisib-updates-may-5 2026-06-03T05:08:33.107Z monthly 0.5 https://novapharmanews.com/us/news/neurocrine-ingrezza-tardive-dyskinesia-improvement-threshold-study 2026-06-03T05:08:35.120Z monthly 0.5 https://novapharmanews.com/us/news/novo-nordisk-denecimig-hemophilia-a-phase-3-trial-nejm 2026-06-03T05:08:37.143Z monthly 0.5 https://novapharmanews.com/us/news/addex-gabab-pam-ipf-chronic-cough-preclinical-results 2026-06-03T05:08:39.114Z monthly 0.5 https://novapharmanews.com/us/news/iga-nephropathy-market-forecast-2036-novartis-zigakibart-immunotherapies 2026-06-03T05:08:41.112Z monthly 0.5 https://novapharmanews.com/us/news/perimeter-medical-claire-oct-ai-fda-approval-breast-cancer-surgery 2026-06-03T05:08:43.119Z monthly 0.5 https://novapharmanews.com/us/news/regeneron-q1-2026-earnings-dupixent-eylea-hd-sales-growth 2026-06-03T05:08:45.114Z monthly 0.5 https://novapharmanews.com/us/news/sprout-pharmaceuticals-addyi-flibanserin-time-top-10-influential-health-companies-2026 2026-06-03T05:08:47.131Z monthly 0.5 https://novapharmanews.com/eu/news/biopharma-clinical-trials-eu-daily-insights 2026-06-03T05:08:49.135Z monthly 0.5 https://novapharmanews.com/us/news/clinical-outsourcing-2026-key-takeaways 2026-06-03T05:08:55.291Z monthly 0.5 https://novapharmanews.com/us/news/clinical-outsourcing-trends-2026-key-takeaways 2026-06-03T05:08:53.121Z monthly 0.5 https://novapharmanews.com/us/news/ieee-cog-2026-industry-day-game-dev-tutorials 2026-06-03T05:08:55.147Z monthly 0.5 https://novapharmanews.com/apac/news/chinabio-partnering-forum-2026-highlights 2026-06-03T05:08:57.134Z monthly 0.5 https://novapharmanews.com/us/news/pharma-partnering-us-biotech-dealmaking 2026-06-03T05:08:59.134Z monthly 0.5 https://novapharmanews.com/us/news/clinical-outsourcing-group-pharma-takeaways 2026-06-03T05:09:01.139Z monthly 0.5 https://novapharmanews.com/apac/news/chinabio-partnering-forum-biotech-deals-apac 2026-06-03T05:09:03.138Z monthly 0.5 https://novapharmanews.com/apac/news/insilico-rentosertib-inhalation-ind-clearance-ai-drug-clinical-trial 2026-06-03T05:09:05.141Z monthly 0.5 https://novapharmanews.com/apac/news/thailand-asean-medical-device-market-gateway-2029 2026-06-03T05:09:07.147Z monthly 0.5 https://novapharmanews.com/apac/news/yangtze-river-pharmaceutical-group-international-revenue-growth-2025 2026-06-03T05:09:09.146Z monthly 0.5 https://novapharmanews.com/apac/news/soleno-therapeutics-securities-fraud-lawsuit-phase-3-clinical-trials 2026-06-03T05:09:11.148Z monthly 0.5 https://novapharmanews.com/apac/news/newleos-ntx-2001-phase-1b-trial-alcohol-use-disorder 2026-06-03T05:09:36.543Z monthly 0.5 https://novapharmanews.com/apac/news/citius-oncology-lymphir-first-international-shipment-europe 2026-06-03T05:09:15.150Z monthly 0.5 https://novapharmanews.com/apac/news/eirgenix-japan-biosimilar-expansion-cphi-2026 2026-06-03T05:09:17.154Z monthly 0.5 https://novapharmanews.com/eu/news/european-commission-approves-poherdy-pertuzumab-biosimilar-henlius-organon 2026-06-03T05:09:19.165Z monthly 0.5 https://novapharmanews.com/eu/news/puretech-lyt-200-clinical-results-myeloid-malignancies-2025 2026-06-03T05:09:21.161Z monthly 0.5 https://novapharmanews.com/eu/news/enterobiotix-19m-funding-phase-2b-ibs-microbiome-trial 2026-06-03T05:09:23.284Z monthly 0.5 https://novapharmanews.com/eu/news/ray-therapeutics-rtx-015-ema-prime-designation-retinitis-pigmentosa 2026-06-03T05:09:25.175Z monthly 0.5 https://novapharmanews.com/eu/news/x4-pharmaceuticals-xolremdi-mavorixafor-european-approval-whim-syndrome 2026-06-03T05:09:27.178Z monthly 0.5 https://novapharmanews.com/eu/news/norgine-xolremdi-mavorixafor-whim-syndrome-european-approval 2026-06-03T05:09:29.168Z monthly 0.5 https://novapharmanews.com/eu/news/norgine-xolremdi-mavorixafor-european-approval-whim-syndrome-treatment 2026-06-03T05:09:36.625Z monthly 0.5 https://novapharmanews.com/eu/news/ema-expert-panel-covid-19-mrna-vaccine-trust-spikevax-comirnaty 2026-06-03T05:09:36.395Z monthly 0.5 https://novapharmanews.com/eu/news/henlius-organon-poherdy-first-pertuzumab-biosimilar-approved-europe 2026-06-03T05:09:42.786Z monthly 0.5 https://novapharmanews.com/us/news/fda-clinical-hold-newron-evenamide-phase-3-trial-treatment-resistant-schizophrenia 2026-06-03T05:09:37.279Z monthly 0.5 https://novapharmanews.com/us/news/teva-q1-2026-results-ponlimsi-fda-approval-olanzapine-lai 2026-06-03T05:09:39.186Z monthly 0.5 https://novapharmanews.com/us/news/teva-acquires-emalex-ecopipam-tourette-syndrome-drug 2026-06-03T05:09:41.194Z monthly 0.5 https://novapharmanews.com/us/news/teva-ponlimsi-biosimilar-fda-approval-prolia-q1-2026-results 2026-06-03T05:24:05.438Z monthly 0.5 https://novapharmanews.com/us/news/bayer-asundexian-stroke-trial-esoc-2026-abstracts 2026-06-03T05:09:45.183Z monthly 0.5 https://novapharmanews.com/us/news/tempest-therapeutics-tpst-2003-car-t-multiple-myeloma-isct-2026 2026-06-03T05:09:47.198Z monthly 0.5 https://novapharmanews.com/us/news/pfizer-elrexfio-progression-free-survival-multiple-myeloma-phase-3-trial 2026-06-03T05:09:49.201Z monthly 0.5 https://novapharmanews.com/us/news/rein-therapeutics-lti-03-phase-2-trial-enrollment-update-ipf 2026-06-03T05:09:51.187Z monthly 0.5 https://novapharmanews.com/us/news/laguna-biotherapeutics-fda-clearance-lgna-100-pediatric-leukemia-trial 2026-06-03T05:09:53.193Z monthly 0.5 https://novapharmanews.com/us/news/expression-therapeutics-fda-fast-track-hemophilia-a-stem-cell-therapy 2026-06-03T05:27:45.116Z monthly 0.5 https://novapharmanews.com/us/news/fda-priority-review-gilead-bictegravir-lenacapavir-hiv-treatment 2026-06-03T05:09:57.208Z monthly 0.5 https://novapharmanews.com/us/news/regeneron-otarmeni-gene-therapy-free-hearing-loss-government-agreement 2026-06-03T05:09:59.195Z monthly 0.5 https://novapharmanews.com/eu/news/eu-biopharma-clinical-trials-daily-roundup 2026-06-03T05:10:01.204Z monthly 0.5 https://novapharmanews.com/us/news/pharma-partnering-us-biotech-deals 2026-06-03T05:10:07.886Z monthly 0.5 https://novapharmanews.com/us/news/cog-2024-daily-highlights 2026-06-03T05:10:05.212Z monthly 0.5 https://novapharmanews.com/apac/news/chinabio-partnering-forum-biotech-deals-investment 2026-06-03T05:10:07.202Z monthly 0.5 https://novapharmanews.com/us/news/asco-2026-oncology-data-readouts 2026-06-03T05:14:47.593Z monthly 0.5 https://novapharmanews.com/us/news/asco-2026-oncology-trials-preview 2026-06-03T05:15:01.185Z monthly 0.5 https://novapharmanews.com/us/news/fda-redi-conference-2026-regulatory-strategies 2026-06-03T05:10:13.213Z monthly 0.5 https://novapharmanews.com/eu/news/eu-biopharma-clinical-trials-daily-insights 2026-06-03T05:10:15.214Z monthly 0.5 https://novapharmanews.com/us/news/pharma-partnering-us-biotech-deals-investment 2026-06-03T05:10:17.214Z monthly 0.5 https://novapharmanews.com/us/news/pharma-partnering-us-biotech-deals-day-1 2026-06-03T05:10:19.215Z monthly 0.5 https://novapharmanews.com/apac/news/trialcliniq-150k-investment-caduceus-capital-ai-clinical-trial-recruitment 2026-06-03T05:10:21.233Z monthly 0.5 https://novapharmanews.com/apac/news/argo-biopharma-bw-50218-phase-1-trial-first-patient-sirna-therapy 2026-06-03T05:10:29.924Z monthly 0.5 https://novapharmanews.com/apac/news/claruvis-retoxin-first-recombinant-botulinum-toxin-approval-china 2026-06-03T05:10:25.226Z monthly 0.5 https://novapharmanews.com/apac/news/jyong-biotech-botreso-botanical-drug-market-access-strategy-2026 2026-06-03T05:10:27.306Z monthly 0.5 https://novapharmanews.com/apac/news/arcera-life-sciences-fosun-pharma-neurodegenerative-disease-collaboration 2026-06-03T05:10:29.244Z monthly 0.5 https://novapharmanews.com/apac/news/samsung-bioepis-atlatl-partnership-asia-pacific-biotech-innovation 2026-06-03T05:10:31.242Z monthly 0.5 https://novapharmanews.com/apac/news/tga-implantable-medical-devices-regulatory-framework-australia-2024 2026-06-03T05:10:37.249Z monthly 0.5 https://novapharmanews.com/apac/news/immunic-appoints-michael-panzara-chief-medical-officer-vidofludimus-calcium 2026-06-03T05:10:35.252Z monthly 0.5 https://novapharmanews.com/apac/news/zhengye-biotechnology-fiscal-2025-financial-results-veterinary-vaccines 2026-06-03T05:10:37.246Z monthly 0.5 https://novapharmanews.com/eu/news/vivosim-labs-ai-tool-predicts-drug-diarrhea-without-animal-testing 2026-06-03T05:10:39.235Z monthly 0.5 https://novapharmanews.com/eu/news/boehringer-ingelheim-survodutide-weight-loss-phase-2-trial-results 2026-06-03T05:10:41.244Z monthly 0.5 https://novapharmanews.com/eu/news/idorsia-quviviq-74-percent-sales-growth-q1-2026-european-expansion 2026-06-03T05:10:43.245Z monthly 0.5 https://novapharmanews.com/eu/news/small-molecule-api-market-202-billion-2036-generic-drugs 2026-06-03T05:10:45.237Z monthly 0.5 https://novapharmanews.com/eu/news/silexion-therapeutics-sil204-phase-2-3-trial-kras-pancreatic-cancer 2026-06-03T05:10:47.249Z monthly 0.5 https://novapharmanews.com/eu/news/novo-nordisk-wegovy-data-women-obesity-european-congress-2026 2026-06-03T05:10:49.250Z monthly 0.5 https://novapharmanews.com/eu/news/solid-biosciences-sgt-003-european-orphan-drug-designation-duchenne-muscular-dystrophy 2026-06-03T05:10:51.327Z monthly 0.5 https://novapharmanews.com/eu/news/cytokinetics-myqorzo-aficamten-esc-heart-failure-2026-congress 2026-06-03T05:10:53.249Z monthly 0.5 https://novapharmanews.com/eu/news/artiva-biotherapeutics-allonk-fda-fast-track-rheumatoid-arthritis 2026-06-03T05:11:05.338Z monthly 0.5 https://novapharmanews.com/eu/news/sq-innovation-lasix-onyu-ce-marking-approval-european-market 2026-06-03T05:10:57.258Z monthly 0.5 https://novapharmanews.com/us/news/aop-health-rapiblyk-landiolol-first-patient-treatment-us 2026-06-03T05:10:59.269Z monthly 0.5 https://novapharmanews.com/us/news/emergent-biosolutions-substipharm-japanese-encephalitis-vaccine-manufacturing-partnership 2026-06-03T05:11:01.261Z monthly 0.5 https://novapharmanews.com/us/news/cordis-selution-slr-drug-eluting-balloon-japan-launch 2026-06-03T05:11:03.262Z monthly 0.5 https://novapharmanews.com/us/news/zealand-pharma-survodutide-weight-loss-phase-3-trial-results 2026-06-03T05:23:18.247Z monthly 0.5 https://novapharmanews.com/us/news/ashvattha-therapeutics-migaldendranib-diabetic-macular-edema-amd-data 2026-06-03T05:11:07.267Z monthly 0.5 https://novapharmanews.com/us/news/aclaris-ati-052-phase-1a-trial-results-45-day-half-life 2026-06-03T05:11:09.275Z monthly 0.5 https://novapharmanews.com/us/news/trevi-therapeutics-q1-2026-earnings-haduvio-chronic-cough-updates 2026-06-03T05:11:11.283Z monthly 0.5 https://novapharmanews.com/us/news/soligenix-hybryte-phase-3-flash2-trial-interim-results-ctcl 2026-06-03T05:11:13.282Z monthly 0.5 https://novapharmanews.com/us/news/avicanna-us-cannabis-rescheduling-medical-research-development 2026-06-03T05:14:00.725Z monthly 0.5 https://novapharmanews.com/us/news/innocare-orelabrutinib-phase-3-trial-sle-treatment 2026-06-03T05:11:17.284Z monthly 0.5 https://novapharmanews.com/us/news/orca-bio-orca-q-fda-rmat-designation-blood-cancers 2026-06-03T05:11:23.781Z monthly 0.5 https://novapharmanews.com/us/news/formblends-2026-peptide-report-rfk-hhs-glp1-therapy-access 2026-06-03T05:11:21.290Z monthly 0.5 https://novapharmanews.com/us/news/c-ray-therapeutics-fda-copper-64-drug-master-file-approval 2026-06-03T05:11:23.285Z monthly 0.5 https://novapharmanews.com/us/news/brc-therapeutics-fda-clearance-brc-002-phase-1-trial-crps 2026-06-03T05:14:00.523Z monthly 0.5 https://novapharmanews.com/us/news/vanda-pharmaceuticals-imsidolimab-generalized-pustular-psoriasis-nejm-evidence 2026-06-03T05:11:27.282Z monthly 0.5 https://novapharmanews.com/us/news/astrazeneca-breztri-aerosphere-approved-first-triple-therapy-asthma-patients-12-older 2026-06-03T05:11:29.289Z monthly 0.5 https://novapharmanews.com/us/news/vensica-medical-fda-ind-approval-vixe-xeomin-needle-free-delivery-overactive-bladder 2026-06-03T05:11:31.308Z monthly 0.5 https://novapharmanews.com/us/news/abbvie-upadacitinib-rinvoq-fda-application-alopecia-areata 2026-06-03T05:11:38.969Z monthly 0.5 https://novapharmanews.com/us/news/novartis-q1-2026-earnings-remibrutinib-chmp-approval-pipeline-growth 2026-06-03T05:11:35.314Z monthly 0.5 https://novapharmanews.com/us/news/wave-life-sciences-wve-007-phase-2a-fda-approval-obesity-diabetes 2026-06-03T05:11:37.301Z monthly 0.5 https://novapharmanews.com/eu/news/biopharma-clinical-trials-daily-roundup 2026-06-03T05:11:39.300Z monthly 0.5 https://novapharmanews.com/us/news/pharma-partnering-us-emergent-evolveimmune-deals 2026-06-03T05:11:47.190Z monthly 0.5 https://novapharmanews.com/us/news/pharma-partnering-us-deal-surge-lilly-sun 2026-06-03T05:11:43.324Z monthly 0.5 https://novapharmanews.com/apac/news/chinabio-partnering-forum-biotech-investment-trends 2026-06-03T05:11:45.306Z monthly 0.5 https://novapharmanews.com/us/news/pharma-compliance-congress-annex-1-challenges 2026-06-03T05:11:47.307Z monthly 0.5 https://novapharmanews.com/us/news/cog-2024-day-1-highlights 2026-06-03T05:11:49.303Z monthly 0.5 https://novapharmanews.com/us/news/clinical-outsourcing-group-event-day-1 2026-06-03T05:11:51.310Z monthly 0.5 https://novapharmanews.com/us/news/clinical-outsourcing-group-daily-roundup 2026-06-03T05:11:54.572Z monthly 0.5 https://novapharmanews.com/us/news/ascrs-2026-opus-genetics-phentolamine-preview 2026-06-03T05:11:55.321Z monthly 0.5 https://novapharmanews.com/us/news/fdli-2026-fda-strategic-priorities 2026-06-03T05:11:57.391Z monthly 0.5 https://novapharmanews.com/us/news/cog-2024-day-1-roundup 2026-06-03T05:12:02.744Z monthly 0.5 https://novapharmanews.com/us/news/clinical-outsourcing-group-2026-daily-roundup 2026-06-03T05:12:01.327Z monthly 0.5 https://novapharmanews.com/apac/news/akso-health-group-brain-computer-interface-rd-program-neurotechnology 2026-06-03T05:12:03.342Z monthly 0.5 https://novapharmanews.com/apac/news/evofem-solosec-distribution-agreement-sub-saharan-africa 2026-06-03T05:12:05.331Z monthly 0.5 https://novapharmanews.com/apac/news/psg-2026-specialty-drug-benefits-report-cost-management-coverage-strategies 2026-06-03T05:12:07.341Z monthly 0.5 https://novapharmanews.com/apac/news/wuxi-apptec-q1-2026-revenue-growth-backlog-results 2026-06-03T05:12:09.331Z monthly 0.5 https://novapharmanews.com/apac/news/img-pharma-acquires-matsumoto-pharmaceutical-japan-expansion 2026-06-03T05:12:11.333Z monthly 0.5 https://novapharmanews.com/apac/news/aquestive-therapeutics-anaphylm-class-action-lawsuit-approval-timeline 2026-06-03T05:12:13.339Z monthly 0.5 https://novapharmanews.com/apac/news/biomarin-completes-amicus-therapeutics-acquisition-galafold-pompe-therapies 2026-06-03T05:12:15.337Z monthly 0.5 https://novapharmanews.com/eu/news/elanco-negasunt-tanidil-emergency-authorization-screwworm-livestock 2026-06-03T05:12:17.340Z monthly 0.5 https://novapharmanews.com/eu/news/opella-essentiale-excel-trial-fatty-liver-disease-masld-results 2026-06-03T05:12:19.358Z monthly 0.5 https://novapharmanews.com/eu/news/advanced-bifurcation-systems-acquires-svelte-medical-coronary-stent-deal 2026-06-03T05:12:21.343Z monthly 0.5 https://novapharmanews.com/eu/news/zentiva-appeals-eu-court-urban-wastewater-directive-generic-medicines 2026-06-03T05:30:36.291Z monthly 0.5 https://novapharmanews.com/eu/news/ab-science-loan-repayment-deferral-agreement-2026 2026-06-03T05:12:25.351Z monthly 0.5 https://novapharmanews.com/eu/news/mundipharma-rezzayo-rezafungin-phase-iii-respect-trial-results-fungal-disease-prevention 2026-06-03T05:12:27.354Z monthly 0.5 https://novapharmanews.com/eu/news/crinetics-palsonify-paltusotine-eu-approval-acromegaly-treatment 2026-06-03T05:12:29.356Z monthly 0.5 https://novapharmanews.com/us/news/cellenkos-fda-clearance-ck0801-phase-2-aplastic-anemia-trial 2026-06-03T05:12:31.365Z monthly 0.5 https://novapharmanews.com/us/news/astrazeneca-saphnelo-autoinjector-fda-approved-lupus-self-administration 2026-06-03T05:12:33.354Z monthly 0.5 https://novapharmanews.com/us/news/dmx-200-action3-trial-statistical-power-blinded-review 2026-06-03T05:12:35.364Z monthly 0.5 https://novapharmanews.com/us/news/concept-medical-sirona-trial-3-year-data-charing-cross-2026 2026-06-03T05:31:24.424Z monthly 0.5 https://novapharmanews.com/us/news/intellia-lonvo-z-fda-submission-crispr-hereditary-angioedema 2026-06-03T05:12:39.370Z monthly 0.5 https://novapharmanews.com/us/news/cordis-selution-slr-drug-eluting-balloon-japan-launch-2026 2026-06-03T05:12:41.375Z monthly 0.5 https://novapharmanews.com/us/news/tovecimig-biliary-tract-cancer-trial-results-companion-002 2026-06-03T05:12:43.368Z monthly 0.5 https://novapharmanews.com/us/news/intellia-lonvoguran-ziclumeran-phase-3-hereditary-angioedema-gene-editing 2026-06-03T05:12:45.366Z monthly 0.5 https://novapharmanews.com/us/news/sagimet-biosciences-denifanstat-phase-3-acne-trial-2026 2026-06-03T05:12:47.448Z monthly 0.5 https://novapharmanews.com/us/news/apollomics-vebreltinib-phase-2-3-ind-submission-nsclc-treatment 2026-06-03T05:12:54.277Z monthly 0.5 https://novapharmanews.com/us/news/aclaris-therapeutics-ati-052-phase-1a-results-ati-2138-update-april-2026 2026-06-03T05:12:51.511Z monthly 0.5 https://novapharmanews.com/us/news/ose-immunotherapeutics-pegrizeprument-vel-101-fda-orphan-drug-designation-heart-transplant 2026-06-03T05:12:53.477Z monthly 0.5 https://novapharmanews.com/us/news/jazz-pharmaceuticals-ziihera-fda-priority-review-her2-cancer 2026-06-03T05:12:55.394Z monthly 0.5 https://novapharmanews.com/us/news/nccn-adds-nuvation-bio-taletrectinib-ibtrozi-cancer-guidelines-ros1-nsclc-brain-metastases 2026-06-03T05:12:57.391Z monthly 0.5 https://novapharmanews.com/us/news/fda-priority-review-imaavy-nipocalimab-warm-autoimmune-hemolytic-anemia 2026-06-03T05:12:59.389Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-caplyta-lumateperone-snda-schizophrenia-relapse-prevention 2026-06-03T05:13:01.385Z monthly 0.5 https://novapharmanews.com/us/news/apotex-fda-approval-generic-infuvite-pediatric-injection-exclusivity 2026-06-03T05:13:03.388Z monthly 0.5 https://novapharmanews.com/us/news/clinical-outsourcing-group-pharma-news-roundup-april-28-2026 2026-06-03T05:13:05.397Z monthly 0.5 https://novapharmanews.com/us/news/4th-annual-cog-2026-no-pharma-news 2026-06-03T05:13:07.386Z monthly 0.5 https://novapharmanews.com/us/news/pharma-compliance-congress-day-1-roundup 2026-06-03T05:13:09.396Z monthly 0.5 https://novapharmanews.com/us/news/acrp-2026-patient-centric-trials-workforce 2026-06-03T05:13:11.395Z monthly 0.5 https://novapharmanews.com/us/news/pharma-compliance-congress-regulatory-updates-day-1 2026-06-03T05:13:13.399Z monthly 0.5 https://novapharmanews.com/us/news/testosterone-therapy-fda-update-regulatory-advances 2026-06-03T05:13:15.407Z monthly 0.5 https://novapharmanews.com/us/news/glp-1-eating-disorder-risk-true-facts 2026-06-03T05:13:21.269Z monthly 0.5 https://novapharmanews.com/us/news/aacr-2026-ai-pathology-oncolytic-virus 2026-06-03T05:13:19.410Z monthly 0.5 https://novapharmanews.com/us/news/interphex-2026-phillips-medisize-sensing 2026-06-03T05:13:21.490Z monthly 0.5 https://novapharmanews.com/eu/news/reuters-pharma-ai-patient-centricity 2026-06-03T05:13:23.423Z monthly 0.5 https://novapharmanews.com/eu/news/pharma-2026-eu-biopharma-medtech-highlights 2026-06-03T05:13:25.413Z monthly 0.5 https://novapharmanews.com/eu/news/reuters-pharma-eu-funding-dealmaking-highlights 2026-06-03T05:13:27.437Z monthly 0.5 https://novapharmanews.com/eu/news/asco-2026-olverembatinib-gastric-cancer-trials 2026-06-03T05:13:29.420Z monthly 0.5 https://novapharmanews.com/eu/news/pharma-sustainability-2026-packaging-preview 2026-06-03T05:13:31.454Z monthly 0.5 https://novapharmanews.com/us/news/pharma-compliance-congress-day-1-regulatory-updates 2026-06-03T05:13:33.425Z monthly 0.5 https://novapharmanews.com/apac/news/eyebright-medical-2025-annual-report-sustainability-results 2026-06-03T05:13:35.431Z monthly 0.5 https://novapharmanews.com/apac/news/pmda-japanese-pharmacopoeia-medical-device-standards-regulatory-science 2026-06-03T05:13:37.431Z monthly 0.5 https://novapharmanews.com/eu/news/boston-scientific-securities-class-action-lawsuit-may-2026 2026-06-03T05:13:39.431Z monthly 0.5 https://novapharmanews.com/eu/news/brii-bio-elebsiran-hepatitis-b-control-apasl-2026-analysis 2026-06-03T05:13:41.431Z monthly 0.5 https://novapharmanews.com/us/news/ascletis-asc30-oral-glp-1-diabetes-phase-2-trial-enrollment-complete 2026-06-03T05:13:43.459Z monthly 0.5 https://novapharmanews.com/us/news/ascletis-asc30-phase-ii-enrollment-complete-oral-glp1-diabetes 2026-06-03T05:13:45.432Z monthly 0.5 https://novapharmanews.com/us/news/sun-pharma-acquires-organon-11-75-billion-merger-2026 2026-06-03T05:13:47.458Z monthly 0.5 https://novapharmanews.com/us/news/boston-scientific-farapulse-watchman-heart-rhythm-2026-data 2026-06-03T05:13:49.442Z monthly 0.5 https://novapharmanews.com/us/news/veradermics-vdphl01-phase-2-3-trial-results-male-pattern-hair-loss 2026-06-03T05:13:51.448Z monthly 0.5 https://novapharmanews.com/us/news/veradermics-vdphl01-phase-2-3-trial-results-conference-call 2026-06-03T05:13:53.461Z monthly 0.5 https://novapharmanews.com/us/news/adagio-medical-vclas-ventricular-ablation-system-pivotal-trial-results 2026-06-03T05:13:55.445Z monthly 0.5 https://novapharmanews.com/us/news/pharma-compliance-congress-2026-opens 2026-06-03T05:13:57.460Z monthly 0.5 https://novapharmanews.com/us/news/acrp-2026-immunology-daily-roundup 2026-06-03T05:13:59.449Z monthly 0.5 https://novapharmanews.com/apac/news/pmc-organometallix-price-increase-all-products-may-2026 2026-06-03T05:14:01.465Z monthly 0.5 https://novapharmanews.com/apac/news/tga-personalised-medical-device-regulations-guidance-2024 2026-06-03T05:14:03.453Z monthly 0.5 https://novapharmanews.com/us/news/atara-biotherapeutics-securities-class-action-lawsuit-may-2026-deadline 2026-06-03T05:14:05.455Z monthly 0.5 https://novapharmanews.com/us/news/aquestive-therapeutics-class-action-lawsuit-fda-application 2026-06-03T05:14:07.461Z monthly 0.5 https://novapharmanews.com/us/news/pulse-biosciences-npulse-cardiac-catheter-heart-rhythm-2026-trial-data 2026-06-03T05:14:09.473Z monthly 0.5 https://novapharmanews.com/us/news/abbott-tactiflex-duo-ablation-catheter-afib-results-hrs-2026 2026-06-03T05:14:11.474Z monthly 0.5 https://novapharmanews.com/us/news/medtronic-affera-sphere-9-catheter-fda-breakthrough-device-designation-ventricular-tachycardia 2026-06-03T05:14:13.460Z monthly 0.5 https://novapharmanews.com/eu/news/ema-positive-opinion-rexatilux-ranibizumab-eye-treatment 2026-06-03T05:14:15.480Z monthly 0.5 https://novapharmanews.com/eu/news/ema-positive-opinion-redemplo-plozasiran-european-approval 2026-06-03T05:14:17.628Z monthly 0.5 https://novapharmanews.com/eu/news/ema-positive-opinion-viatris-palbociclib-generic-cancer-treatment 2026-06-03T05:14:19.470Z monthly 0.5 https://novapharmanews.com/eu/news/ema-positive-opinion-itvisma-onasemnogene-abeparvovec-sma-gene-therapy 2026-06-03T05:14:21.482Z monthly 0.5 https://novapharmanews.com/eu/news/ema-positive-opinion-cenrifki-tolebrutinib-multiple-sclerosis 2026-06-03T05:14:23.489Z monthly 0.5 https://novapharmanews.com/eu/news/ema-approves-first-rna-veterinary-vaccine-nobivac-nxt-cats 2026-06-03T05:14:25.482Z monthly 0.5 https://novapharmanews.com/eu/news/ema-approves-plozasiran-redemplo-familial-chylomicronaemia-syndrome-fcs 2026-06-03T05:14:27.484Z monthly 0.5 https://novapharmanews.com/eu/news/ema-chmp-recommends-tolebrutinib-cenrifki-five-medicines-approval-april-2026 2026-06-03T05:14:29.482Z monthly 0.5 https://novapharmanews.com/us/news/fda-gdufa-generic-drug-user-fee-amendments-2024-updates 2026-06-03T05:14:31.493Z monthly 0.5 https://novapharmanews.com/us/news/fda-omufa-user-fee-program-otc-monograph-drugs 2026-06-03T05:14:33.501Z monthly 0.5 https://novapharmanews.com/us/news/fda-gdufa-iv-reauthorization-2028-2032-generic-drug-user-fees 2026-06-03T05:14:35.493Z monthly 0.5 https://novapharmanews.com/us/news/fda-testosterone-therapy-low-libido-hypogonadism-2024 2026-06-03T05:14:37.497Z monthly 0.5 https://novapharmanews.com/us/news/fda-reduces-animal-testing-drug-development-alternatives-2024 2026-06-03T05:14:39.497Z monthly 0.5 https://novapharmanews.com/us/news/cms-fda-rapid-coverage-pathway-breakthrough-medical-devices-medicare 2026-06-03T05:14:41.507Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-otarmeni-first-gene-therapy-genetic-hearing-loss 2026-06-03T05:14:43.500Z monthly 0.5 https://novapharmanews.com/us/news/fda-accelerates-mental-health-treatment-access-executive-order 2026-06-03T05:14:45.505Z monthly 0.5 https://novapharmanews.com/us/news/acrp-2026-immunology-day-1-roundup 2026-06-03T05:14:47.508Z monthly 0.5 https://novapharmanews.com/us/news/scope-x-2026-clinical-ops-data-ai-boston 2026-06-03T05:14:49.515Z monthly 0.5 https://novapharmanews.com/us/news/oct-east-coast-2026-clinical-trial-innovation 2026-06-03T05:14:51.514Z monthly 0.5 https://novapharmanews.com/apac/news/sunnybrook-41-million-investment-clinical-trials-canada 2026-06-03T05:14:53.526Z monthly 0.5 https://novapharmanews.com/apac/news/wuxi-biologics-chengdu-microbial-manufacturing-completion-2026 2026-06-03T05:14:55.531Z monthly 0.5 https://novapharmanews.com/apac/news/quasar-medical-thailand-manufacturing-facility-medtech-expansion 2026-06-03T05:14:57.611Z monthly 0.5 https://novapharmanews.com/apac/news/daewoong-nabota-master-class-prabotulinumtoxina-safety-2026 2026-06-03T05:15:07.483Z monthly 0.5 https://novapharmanews.com/apac/news/amcor-35m-healthcare-packaging-facility-malaysia-medical-supply-chain 2026-06-03T05:15:01.521Z monthly 0.5 https://novapharmanews.com/apac/news/transcarent-smithrx-partnership-pharmacy-benefits-platform 2026-06-03T05:15:03.518Z monthly 0.5 https://novapharmanews.com/apac/news/hanchorbio-bloomberg-partnership-drug-development-intelligence 2026-06-03T05:15:05.532Z monthly 0.5 https://novapharmanews.com/eu/news/aetna-prior-authorization-reform-88-percent-standardized-2026 2026-06-03T05:15:13.474Z monthly 0.5 https://novapharmanews.com/eu/news/guerbet-lipiodol-ultra-fluid-eu-approval-vascular-embolization 2026-06-03T05:15:09.545Z monthly 0.5 https://novapharmanews.com/eu/news/rna-therapy-clinical-trials-market-3-4-billion-2035-forecast 2026-06-03T05:15:11.553Z monthly 0.5 https://novapharmanews.com/eu/news/oncotelic-therapeutics-partnership-strategy-update-2026 2026-06-03T05:15:13.534Z monthly 0.5 https://novapharmanews.com/eu/news/clinuvel-scenesse-phase-iii-vitiligo-trial-ema-approval-2026 2026-06-03T05:15:15.540Z monthly 0.5 https://novapharmanews.com/us/news/frankfurt-court-upholds-besremi-arbitral-award-aop-health-pharmaessentia 2026-06-03T05:15:19.698Z monthly 0.5 https://novapharmanews.com/us/news/novartis-coartem-baby-who-prequalification-malaria-treatment-newborns 2026-06-03T05:15:19.537Z monthly 0.5 https://novapharmanews.com/us/news/miracell-smart-m-cell-alzheimers-stem-cell-therapy-results 2026-06-03T05:15:21.540Z monthly 0.5 https://novapharmanews.com/us/news/berlin-heals-positive-cmic-iii-heart-failure-device-results 2026-06-03T05:15:23.552Z monthly 0.5 https://novapharmanews.com/us/news/citius-pharmaceuticals-5-million-direct-offering-stock-nasdaq 2026-06-03T05:15:25.547Z monthly 0.5 https://novapharmanews.com/us/news/haemonetics-vascade-mvp-xl-safety-efficacy-study-large-bore-venous-closure 2026-06-03T05:15:27.552Z monthly 0.5 https://novapharmanews.com/us/news/briohealth-solutions-fda-approval-pediatric-briovad-heart-device-trial 2026-06-03T05:15:29.564Z monthly 0.5 https://novapharmanews.com/us/news/cgbio-fda-clearance-easymade-ti-titanium-implant 2026-06-03T05:15:31.566Z monthly 0.5 https://novapharmanews.com/us/news/cerapedics-vizient-supplier-agreement-pearlmatrix-p15-bone-graft 2026-06-03T05:15:33.564Z monthly 0.5 https://novapharmanews.com/us/news/acrp-2026-immunology-clinical-research-day-1 2026-06-03T05:15:35.555Z monthly 0.5 https://novapharmanews.com/us/news/acrp-2026-immunology-clinical-research-daily-roundup 2026-06-03T05:15:37.575Z monthly 0.5 https://novapharmanews.com/us/news/acrp-2026-immunology-clinical-research-trends 2026-06-03T05:15:39.572Z monthly 0.5 https://novapharmanews.com/apac/news/catalym-visugromab-phase-2-3-trial-cancer-cachexia-first-patient-dosed 2026-06-03T05:15:41.575Z monthly 0.5 https://novapharmanews.com/apac/news/spinogenix-spg601-clarity-trial-fragile-x-syndrome-phase-2b-3 2026-06-03T05:15:43.571Z monthly 0.5 https://novapharmanews.com/apac/news/tga-biologicals-regulatory-framework-advanced-therapies-australia 2026-06-03T05:15:45.585Z monthly 0.5 https://novapharmanews.com/eu/news/renovorx-tamp-therapy-asco-2026-tiger-pac-trial-data 2026-06-03T05:15:47.574Z monthly 0.5 https://novapharmanews.com/eu/news/genomics-services-market-24-billion-2033-precision-medicine 2026-06-03T05:15:49.569Z monthly 0.5 https://novapharmanews.com/eu/news/accenture-invests-iridius-ai-compliance-life-sciences 2026-06-03T05:15:51.575Z monthly 0.5 https://novapharmanews.com/eu/news/pharmaceutical-q1-2026-sales-growth-momentum 2026-06-03T05:15:53.574Z monthly 0.5 https://novapharmanews.com/eu/news/cumberland-pharmaceuticals-apotex-strategic-integration-partnership 2026-06-03T05:15:55.572Z monthly 0.5 https://novapharmanews.com/us/news/cortec-brain-interchange-bci-fda-tap-program-stroke-rehabilitation 2026-06-03T05:15:57.576Z monthly 0.5 https://novapharmanews.com/us/news/tivic-health-rebrands-valion-bio-entolimod-acute-radiation-syndrome-fda-fast-track 2026-06-03T05:15:59.625Z monthly 0.5 https://novapharmanews.com/us/news/edwards-lifesciences-q1-2026-results-tmtt-sales-guidance-raise 2026-06-03T05:16:01.684Z monthly 0.5 https://novapharmanews.com/us/news/immunitybio-ibrx-fda-warning-letter-class-action-lawsuit-anktiva 2026-06-03T05:16:03.584Z monthly 0.5 https://novapharmanews.com/us/news/transmedics-chops-organ-preservation-system-ishlt-2026 2026-06-03T05:16:05.589Z monthly 0.5 https://novapharmanews.com/us/news/abbvie-fda-complete-response-letter-trenibotulinumtoxine-trenibote-manufacturing 2026-06-03T05:16:07.607Z monthly 0.5 https://novapharmanews.com/us/news/alpha-tau-fda-approval-alpha-dart-pancreatic-cancer-trial-expansion 2026-06-03T05:16:09.599Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-regeneron-otarmeni-gene-therapy-genetic-hearing-loss 2026-06-03T05:16:11.605Z monthly 0.5 https://novapharmanews.com/us/news/acrp-2026-immunology-parexel-hiring 2026-06-03T05:16:13.590Z monthly 0.5 https://novapharmanews.com/eu/news/reuters-pharma-eu-day1-roundup 2026-06-03T05:16:15.603Z monthly 0.5 https://novapharmanews.com/us/news/generic-drug-forum-2026-highlights 2026-06-03T05:16:17.603Z monthly 0.5 https://novapharmanews.com/eu/news/tilray-brands-us-medical-cannabis-expansion-rescheduling-2026 2026-06-03T05:16:19.623Z monthly 0.5 https://novapharmanews.com/us/news/capricor-therapeutics-hope-3-phase-3-deramiocel-duchenne-muscular-dystrophy-aan-2026 2026-06-03T05:16:24.072Z monthly 0.5 https://novapharmanews.com/us/news/ctoc-a-new-paradigm-in-precision-nutrition-and-health-data-fbd60908 2026-06-03T05:16:23.597Z monthly 0.5 https://novapharmanews.com/us/news/a-secure-and-intelligent-drug-delivery-model-integrating-neural-networks-with-bl-853eecb6 2026-06-03T05:16:25.604Z monthly 0.5 https://novapharmanews.com/us/news/strengths-and-limitations-of-real-world-data-from-electronic-health-records-and-92ed37a9 2026-06-03T05:16:27.605Z monthly 0.5 https://novapharmanews.com/us/news/the-gross-to-net-squeeze-how-physician-led-patient-education-reduces-gtn-erosion-17169d71 2026-06-03T05:16:29.628Z monthly 0.5 https://novapharmanews.com/us/news/the-market-for-monoclonal-antibodies-trends-challenges-and-opportunities-7a342d06 2026-06-03T05:16:31.611Z monthly 0.5 https://novapharmanews.com/us/news/bbsw-ai-solution-event-pharma-ai-future 2026-06-03T05:16:33.614Z monthly 0.5 https://novapharmanews.com/apac/news/samsung-bioepis-sbe303-phase-1-trial-sandoz-partnership-2026 2026-06-03T05:16:35.610Z monthly 0.5 https://novapharmanews.com/apac/news/fosun-health-wins-awards-globalhealth-asia-pacific-forum-2026 2026-06-03T05:16:37.614Z monthly 0.5 https://novapharmanews.com/apac/news/minjuvi-tafasitamab-approved-australia-follicular-lymphoma 2026-06-03T05:16:39.632Z monthly 0.5 https://novapharmanews.com/eu/news/ccbd-car-t-cell-therapy-maryland-community-oncology 2026-06-03T05:16:41.648Z monthly 0.5 https://novapharmanews.com/eu/news/samacare-prior-authorization-benchmarks-medical-benefit-drugs 2026-06-03T05:16:43.627Z monthly 0.5 https://novapharmanews.com/eu/news/repertoire-immune-medicines-rptr-1-201-phase-1-2-trial-advanced-solid-tumors 2026-06-03T05:16:45.627Z monthly 0.5 https://novapharmanews.com/eu/news/alpha-tau-alpha-dart-pancreatic-cancer-acapella-trial-first-patient 2026-06-03T05:16:47.653Z monthly 0.5 https://novapharmanews.com/eu/news/alpha-tau-alpha-dart-pancreatic-cancer-acapella-trial-europe 2026-06-03T05:16:49.633Z monthly 0.5 https://novapharmanews.com/eu/news/blinatumomab-pediatric-leukemia-safety-study-final-stage 2026-06-03T05:16:51.645Z monthly 0.5 https://novapharmanews.com/eu/news/healthcare-third-party-logistics-market-growth-502-billion-2034 2026-06-03T05:16:53.718Z monthly 0.5 https://novapharmanews.com/eu/news/pharmaceutical-intermediates-market-57-billion-2035-generic-drugs 2026-06-03T05:16:55.636Z monthly 0.5 https://novapharmanews.com/us/news/dupixent-approved-pediatric-chronic-spontaneous-urticaria-sanofi-regeneron 2026-06-03T05:16:57.642Z monthly 0.5 https://novapharmanews.com/us/news/ose-immunotherapeutics-tedopi-ovarian-cancer-asco-2026-presentation 2026-06-03T05:16:59.647Z monthly 0.5 https://novapharmanews.com/us/news/nectero-therapeutics-east-system-two-year-safety-data-abdominal-aortic-aneurysm 2026-06-03T05:17:01.642Z monthly 0.5 https://novapharmanews.com/us/news/novo-nordisk-oral-semaglutide-children-type-2-diabetes-pioneer-teens-trial 2026-06-03T05:17:03.663Z monthly 0.5 https://novapharmanews.com/us/news/neurosterix-ntx-253-schizophrenia-phase-1-trial-q2-2026 2026-06-03T05:17:08.697Z monthly 0.5 https://novapharmanews.com/us/news/greenwich-lifesciences-glsi-100-asco-2026-breast-cancer-immunotherapy 2026-06-03T05:17:08.593Z monthly 0.5 https://novapharmanews.com/us/news/mabwell-9mw2821-nectin-4-adc-phase-iii-triple-negative-breast-cancer 2026-06-03T05:17:09.883Z monthly 0.5 https://novapharmanews.com/us/news/clearpoint-neuro-fda-clearance-velocity-alpha-surgical-drill-system 2026-06-03T05:17:11.702Z monthly 0.5 https://novapharmanews.com/us/news/vistagen-refisolone-fda-approval-menopause-hot-flashes-phase-2-trial 2026-06-03T05:17:13.703Z monthly 0.5 https://novapharmanews.com/us/news/avai-bio-fda-cellular-rejuvenation-trial-anti-aging-market-120-billion 2026-06-03T05:17:15.707Z monthly 0.5 https://novapharmanews.com/us/news/cipla-fda-approval-first-generic-ventolin-hfa-albuterol-sulfate 2026-06-03T05:17:17.705Z monthly 0.5 https://novapharmanews.com/us/news/dupixent-approved-chronic-spontaneous-urticaria-children-sanofi 2026-06-03T05:17:19.713Z monthly 0.5 https://novapharmanews.com/us/news/oncology-data-trends-2026-preview 2026-06-03T05:17:22.928Z monthly 0.5 https://novapharmanews.com/us/news/redi-2026-fda-regulatory-strategies-conference-preview 2026-06-03T05:17:23.713Z monthly 0.5 https://novapharmanews.com/us/news/bionj-biopartnering-conference-2026-preview 2026-06-03T05:17:25.761Z monthly 0.5 https://novapharmanews.com/us/news/fierce-biotech-week-2026-boston-preview 2026-06-03T05:17:27.730Z monthly 0.5 https://novapharmanews.com/eu/news/reuters-pharma-day-1-eu-takeaways 2026-06-03T05:17:29.768Z monthly 0.5 https://novapharmanews.com/us/news/biomed-israel-2026-ai-biotech-preview 2026-06-03T05:17:31.750Z monthly 0.5 https://novapharmanews.com/eu/news/reuters-pharma-eu-day-1-roundup 2026-06-03T05:17:33.730Z monthly 0.5 https://novapharmanews.com/us/news/oct-east-coast-2026-cro-trends-outsourcing 2026-06-03T05:17:35.753Z monthly 0.5 https://novapharmanews.com/us/news/interphex-2026-biotech-day-1-roundup 2026-06-03T05:17:37.739Z monthly 0.5 https://novapharmanews.com/apac/news/calluna-pharma-cal101-phase-2-enrollment-ipf-treatment 2026-06-03T05:17:39.747Z monthly 0.5 https://novapharmanews.com/apac/news/anixa-biosciences-lira-cel-car-t-ovarian-cancer-survival-data 2026-06-03T05:17:41.750Z monthly 0.5 https://novapharmanews.com/apac/news/hengrui-pharma-q1-2026-anti-pd-l1-tgf-beta-fusion-protein-approved-china 2026-06-03T05:17:43.777Z monthly 0.5 https://novapharmanews.com/apac/news/sonorous-neurovascular-fda-clearance-boscath-catheter-2026 2026-06-03T05:17:45.765Z monthly 0.5 https://novapharmanews.com/apac/news/alphamab-oncology-jskn016-trop2-her3-bispecific-adc-her2-negative-breast-cancer-asco-2026 2026-06-03T05:17:47.774Z monthly 0.5 https://novapharmanews.com/apac/news/rfid-technology-pharmaceutical-supply-chain-15-billion-2032 2026-06-03T05:17:49.757Z monthly 0.5 https://novapharmanews.com/apac/news/wuxi-biologics-south-korea-gmp-certification-bispecific-antibody-manufacturing 2026-06-03T05:17:51.780Z monthly 0.5 https://novapharmanews.com/apac/news/australia-tga-therapeutic-sunscreen-regulatory-framework-2024 2026-06-03T05:17:53.774Z monthly 0.5 https://novapharmanews.com/eu/news/belite-bio-tinlarebant-nda-submission-stargardt-disease-phase-3-dragon-trial 2026-06-03T05:17:55.765Z monthly 0.5 https://novapharmanews.com/eu/news/abivax-obefazimod-phase-3-data-digestive-disease-week-2026 2026-06-03T05:17:57.760Z monthly 0.5 https://novapharmanews.com/eu/news/pet-service-holding-2025-annual-results-veterinary-regulatory-changes 2026-06-03T05:17:59.751Z monthly 0.5 https://novapharmanews.com/eu/news/femasys-femaseed-complete-fertility-solution-obgyn-acog-2026 2026-06-03T05:18:01.761Z monthly 0.5 https://novapharmanews.com/eu/news/mauna-kea-technologies-ce-mark-mdr-approval-european-expansion 2026-06-03T05:18:03.758Z monthly 0.5 https://novapharmanews.com/eu/news/pembrolizumab-lenvatinib-clear-cell-cancer-trial-results 2026-06-03T05:18:05.790Z monthly 0.5 https://novapharmanews.com/eu/news/roche-gazyva-fda-acceptance-lupus-treatment-phase-iii-allegory 2026-06-03T05:18:07.757Z monthly 0.5 https://novapharmanews.com/eu/news/dupixent-first-biologic-approved-chronic-spontaneous-urticaria-children 2026-06-03T05:18:09.757Z monthly 0.5 https://novapharmanews.com/eu/news/ipsen-ojemda-tovorafenib-eu-approval-pediatric-brain-cancer-braf 2026-06-03T05:18:11.760Z monthly 0.5 https://novapharmanews.com/us/news/alterity-ath434-multiple-system-atrophy-phase-2-results 2026-06-03T05:18:20.279Z monthly 0.5 https://novapharmanews.com/us/news/tempest-therapeutics-tpst-2003-car-t-manufacturing-milestone-2026 2026-06-03T05:18:15.757Z monthly 0.5 https://novapharmanews.com/us/news/phanes-therapeutics-spevatamig-phase-2-results-pancreatic-cancer-asco-2026 2026-06-03T05:18:17.864Z monthly 0.5 https://novapharmanews.com/us/news/netris-pharma-np137-pancreatic-cancer-phase-1b-nature-results 2026-06-03T05:18:26.932Z monthly 0.5 https://novapharmanews.com/us/news/neurosterix-ntx-253-phase-1-schizophrenia-trial-q2-2026 2026-06-03T05:18:21.764Z monthly 0.5 https://novapharmanews.com/us/news/mabwell-9mw2821-toripalimab-asco-2026-urothelial-carcinoma 2026-06-03T05:18:23.765Z monthly 0.5 https://novapharmanews.com/us/news/fda-complete-response-letter-atara-biotherapeutics-ebvallo-tabelecleucel-securities-lawsuit 2026-06-03T05:18:25.786Z monthly 0.5 https://novapharmanews.com/us/news/immunitybio-ibrx-securities-lawsuit-fda-warning-letter-cancer-claims 2026-06-03T05:18:27.796Z monthly 0.5 https://novapharmanews.com/us/news/nrx-pharmaceuticals-fda-positive-feedback-preservative-free-ketamine-generic 2026-06-03T05:18:29.773Z monthly 0.5 https://novapharmanews.com/us/news/labcorp-fda-approved-pd-l1-companion-diagnostic-keytruda-ovarian-cancer 2026-06-03T05:18:31.783Z monthly 0.5 https://novapharmanews.com/us/news/veloxis-pegrizeprument-fda-orphan-drug-designation-heart-transplant 2026-06-03T05:18:33.780Z monthly 0.5 https://novapharmanews.com/us/news/dupixent-approved-children-chronic-spontaneous-urticaria-csu 2026-06-03T05:18:35.793Z monthly 0.5 https://novapharmanews.com/eu/news/reuters-pharma-eu-daily-roundup 2026-06-03T05:18:37.788Z monthly 0.5 https://novapharmanews.com/eu/news/reuters-pharma-eu-day-1-highlights 2026-06-03T05:18:39.806Z monthly 0.5 https://novapharmanews.com/eu/news/pharma-news-today-opioid-crisis-drug-pricing-supply-chain 2026-06-03T05:18:41.781Z monthly 0.5 https://novapharmanews.com/eu/news/fda-idvynso-ascentage-asco-2026 2026-06-03T05:18:43.799Z monthly 0.5 https://novapharmanews.com/us/news/aacr-2026-oncology-highlights 2026-06-03T05:18:45.796Z monthly 0.5 https://novapharmanews.com/apac/news/kelun-biotech-sacituzumab-tirumotecan-asco-2026-presentations 2026-06-03T05:18:47.792Z monthly 0.5 https://novapharmanews.com/apac/news/novi-health-glp-1-hybrid-care-model-clinical-real-world-gap 2026-06-03T05:18:50.735Z monthly 0.5 https://novapharmanews.com/apac/news/duchesnay-peripharm-regulatory-reform-womens-health-access-canada 2026-06-03T05:18:51.799Z monthly 0.5 https://novapharmanews.com/apac/news/australia-tga-updates-ivd-regulations-medical-device-manufacturers 2026-06-03T05:18:53.802Z monthly 0.5 https://novapharmanews.com/apac/news/washington-state-life-sciences-industry-growth-2024 2026-06-03T05:18:55.901Z monthly 0.5 https://novapharmanews.com/eu/news/redhill-opaganib-neuroblastoma-triple-negative-breast-cancer-aacr-2026 2026-06-03T05:18:57.873Z monthly 0.5 https://novapharmanews.com/eu/news/redhill-opaganib-neuroblastoma-breast-cancer-aacr-2026 2026-06-03T05:18:59.799Z monthly 0.5 https://novapharmanews.com/eu/news/sab-biotherapeutics-sab-142-c-peptide-preservation-type-1-diabetes-phase-1-trial 2026-06-03T05:19:01.816Z monthly 0.5 https://novapharmanews.com/eu/news/boston-scientific-q1-2026-earnings-clinical-trial-results 2026-06-03T05:19:03.816Z monthly 0.5 https://novapharmanews.com/eu/news/cervomed-neflamapimod-brain-volume-increase-dementia-lewy-bodies-aan-2026 2026-06-03T05:19:07.326Z monthly 0.5 https://novapharmanews.com/eu/news/cervomed-neflamapimod-dementia-lewy-bodies-aan-2026-results 2026-06-03T05:19:07.808Z monthly 0.5 https://novapharmanews.com/eu/news/celerion-thl-partners-majority-investment-clinical-research 2026-06-03T05:19:09.809Z monthly 0.5 https://novapharmanews.com/eu/news/veristat-acquires-certara-regulatory-writing-business-european-expansion 2026-06-03T05:19:11.825Z monthly 0.5 https://novapharmanews.com/eu/news/lung-cancer-therapeutics-market-142-billion-precision-medicine-2036 2026-06-03T05:19:13.818Z monthly 0.5 https://novapharmanews.com/eu/news/drug-delivery-devices-market-growth-forecast-2032-biologics 2026-06-03T05:20:21.434Z monthly 0.5 https://novapharmanews.com/eu/news/polycythemia-vera-market-transformation-protagonist-therapeutics-rusfertide-2036 2026-06-03T05:19:17.836Z monthly 0.5 https://novapharmanews.com/eu/news/ipsen-ojemda-tovorafenib-first-targeted-therapy-pediatric-brain-tumors-eu-approval 2026-06-03T05:19:19.819Z monthly 0.5 https://novapharmanews.com/eu/news/sanofi-tzield-fda-approval-children-type-1-diabetes-delay 2026-06-03T05:19:21.825Z monthly 0.5 https://novapharmanews.com/us/news/denali-therapeutics-fda-approval-avlayah-tividenofusp-alfa-hunter-syndrome 2026-06-03T05:19:23.828Z monthly 0.5 https://novapharmanews.com/us/news/pfizer-lorbrena-braftovi-asco-2026-cancer-trials 2026-06-03T05:19:25.842Z monthly 0.5 https://novapharmanews.com/us/news/capricor-deramiocel-phase-3-hope-3-duchenne-muscular-dystrophy-aan-2026 2026-06-03T05:19:27.834Z monthly 0.5 https://novapharmanews.com/us/news/boston-scientific-q1-2026-earnings-results-revenue-growth 2026-06-03T05:19:31.069Z monthly 0.5 https://novapharmanews.com/us/news/ractigen-rag-17-als-phase-1-trial-results-2026 2026-06-03T05:19:31.965Z monthly 0.5 https://novapharmanews.com/us/news/avacta-ava6103-cancer-drug-aacr-2026-data-enhertu-comparison 2026-06-03T05:19:35.355Z monthly 0.5 https://novapharmanews.com/us/news/innovent-ibi363-clinical-data-asco-2026 2026-06-03T05:19:35.845Z monthly 0.5 https://novapharmanews.com/us/news/fda-extends-sanofi-sarclisa-subcutaneous-review-multiple-myeloma 2026-06-03T05:19:37.840Z monthly 0.5 https://novapharmanews.com/us/news/nrx-pharmaceuticals-fda-feedback-preservative-free-ketamine-generic 2026-06-03T05:19:39.867Z monthly 0.5 https://novapharmanews.com/us/news/lupin-launches-generic-dapagliflozin-metformin-xr-tablets-us-xigduo-alternative 2026-06-03T05:19:41.856Z monthly 0.5 https://novapharmanews.com/us/news/sanofi-tzield-fda-approval-children-type-1-diabetes-delay 2026-06-03T05:19:43.843Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-sanofi-tzield-children-type-1-diabetes-delay 2026-06-03T05:31:38.826Z monthly 0.5 https://novapharmanews.com/eu/news/pharma-2026-eu-daily-roundup 2026-06-03T05:19:47.849Z monthly 0.5 https://novapharmanews.com/eu/news/pharma-2026-eu-day-1-roundup 2026-06-03T05:19:49.850Z monthly 0.5 https://novapharmanews.com/us/news/generic-drug-forum-us-market-access 2026-06-03T05:19:51.848Z monthly 0.5 https://novapharmanews.com/us/news/interphex-2026-biotech-innovations-day-1 2026-06-03T05:19:53.851Z monthly 0.5 https://novapharmanews.com/us/news/aacr-2024-daily-oncology-research-roundup 2026-06-03T05:19:55.853Z monthly 0.5 https://novapharmanews.com/eu/news/pharma-news-purdue-sentencing-supply-chain-asco 2026-06-03T05:19:57.870Z monthly 0.5 https://novapharmanews.com/us/news/generic-drugs-forum-2026-fda-event-opens 2026-06-03T05:19:59.859Z monthly 0.5 https://novapharmanews.com/us/news/interphex-2026-avantor-biolife-aes-highlights 2026-06-03T05:20:01.945Z monthly 0.5 https://novapharmanews.com/us/news/aacr-2024-oncology-news-day-1 2026-06-03T05:20:03.869Z monthly 0.5 https://novapharmanews.com/us/news/aacr-2024-oncology-research-highlights-day-1 2026-06-03T05:20:05.869Z monthly 0.5 https://novapharmanews.com/eu/news/slas-europe-2026-lab-automation-screening 2026-06-03T05:20:07.866Z monthly 0.5 https://novapharmanews.com/eu/news/pharma-partnering-eu-2026-biotech-bdl-preview 2026-06-03T05:20:09.875Z monthly 0.5 https://novapharmanews.com/us/news/fda-redi-conference-2026-preview 2026-06-03T05:35:15.306Z monthly 0.5 https://novapharmanews.com/us/news/scopex-2026-causal-ai-ml-clinical-trials-preview 2026-06-03T05:20:20.398Z monthly 0.5 https://novapharmanews.com/us/news/pharma-manufacturing-innovation-us-2026 2026-06-03T05:20:15.878Z monthly 0.5 https://novapharmanews.com/eu/news/eu-pharma-innovation-trends-2026 2026-06-03T05:20:17.959Z monthly 0.5 https://novapharmanews.com/us/news/ispor-2026-cardiology-heor-preview 2026-06-03T05:20:19.889Z monthly 0.5 https://novapharmanews.com/us/news/bbsw-ai-solution-2026-biotech-preview 2026-06-03T05:20:21.892Z monthly 0.5 https://novapharmanews.com/us/news/bio-it-world-2026-ai-oncology-preview 2026-06-03T05:20:23.897Z monthly 0.5 https://novapharmanews.com/us/news/ispor-2026-heor-policy-pharma-pricing 2026-06-03T05:20:25.889Z monthly 0.5 https://novapharmanews.com/us/news/2nd-annual-cog-2026-pharma-preview 2026-06-03T05:20:27.903Z monthly 0.5 https://novapharmanews.com/us/news/biomed-israel-2026-preview 2026-06-03T05:20:29.918Z monthly 0.5 https://novapharmanews.com/us/news/asgct-2026-calidi-biotherapeutics-redtail-preview 2026-06-03T05:20:31.895Z monthly 0.5 https://novapharmanews.com/apac/news/pda-apac-pharma-manufacturing-trends-2026 2026-06-03T05:20:37.439Z monthly 0.5 https://novapharmanews.com/eu/news/isct-2026-cell-gene-therapy-manufacturing-dublin 2026-06-03T05:20:35.904Z monthly 0.5 https://novapharmanews.com/us/news/asgct-2026-gene-therapy-preview 2026-06-03T05:20:37.897Z monthly 0.5 https://novapharmanews.com/us/news/asgct-2026-gene-therapy-manufacturing-preview 2026-06-03T05:20:40.822Z monthly 0.5 https://novapharmanews.com/us/news/thma-cpe-circle-2026-pharma-exec-networking 2026-06-03T05:20:41.981Z monthly 0.5 https://novapharmanews.com/us/news/thma-oncology-forum-2026-pharma-insights 2026-06-03T05:20:43.981Z monthly 0.5 https://novapharmanews.com/eu/news/raps-euro-convergence-2026-eu-mdr-regulatory-tech 2026-06-03T05:20:45.967Z monthly 0.5 https://novapharmanews.com/eu/news/european-research-revolution-clinical-trial-tech 2026-06-03T05:20:49.632Z monthly 0.5 https://novapharmanews.com/us/news/aphl-2026-annual-preview 2026-06-03T05:20:49.978Z monthly 0.5 https://novapharmanews.com/eu/news/swiss-biotech-day-2026-preview 2026-06-03T05:20:51.988Z monthly 0.5 https://novapharmanews.com/us/news/excipient-world-2026-preview 2026-06-03T05:20:54.054Z monthly 0.5 https://novapharmanews.com/us/news/pharma-partnering-us-2026-biotech-dealmaking 2026-06-03T05:20:55.981Z monthly 0.5 https://novapharmanews.com/us/news/pharma-partnering-us-summit-2026-preview 2026-06-03T05:20:57.993Z monthly 0.5 https://novapharmanews.com/eu/news/eu-biopharma-clinical-trials-oncology-asco-aua 2026-06-03T05:21:04.938Z monthly 0.5 https://novapharmanews.com/us/news/clinical-outsourcing-trends-2026 2026-06-03T05:21:02.008Z monthly 0.5 https://novapharmanews.com/us/news/4th-annual-cog-preview 2026-06-03T05:21:09.795Z monthly 0.5 https://novapharmanews.com/apac/news/chinabio-partnering-forum-2026-apac-biotech-preview 2026-06-03T05:21:06.133Z monthly 0.5 https://novapharmanews.com/us/news/pharma-compliance-congress-2026-preview 2026-06-03T05:21:08.140Z monthly 0.5 https://novapharmanews.com/us/news/aacr-2026-pembrolizumab-bowel-cancer-moderna-melanoma 2026-06-03T05:21:10.135Z monthly 0.5 https://novapharmanews.com/us/news/aacr-2026-day3-immunotherapy-kras-mrna 2026-06-03T05:21:17.152Z monthly 0.5 https://novapharmanews.com/us/news/acrp-2026-immunology-clinical-research-preview 2026-06-03T05:21:14.139Z monthly 0.5 https://novapharmanews.com/eu/news/reuters-pharma-2024-preview 2026-06-03T05:21:16.148Z monthly 0.5 https://novapharmanews.com/eu/news/reuters-pharma-2024-preview-eu 2026-06-03T05:21:18.136Z monthly 0.5 https://novapharmanews.com/apac/news/suvoda-agentic-ai-rtsm-clinical-trial-startup-reduction 2026-06-03T05:21:20.155Z monthly 0.5 https://novapharmanews.com/apac/news/dayspring-pharma-cg2001-foam-phase-ii-trial-androgenetic-alopecia-results 2026-06-03T05:21:22.144Z monthly 0.5 https://novapharmanews.com/apac/news/myome-board-appointments-healthcare-leaders-ai-genomics 2026-06-03T05:21:24.152Z monthly 0.5 https://novapharmanews.com/apac/news/synbiotech-l-plantarum-fs4722-hyperuricemia-prevention-preclinical 2026-06-03T05:22:52.427Z monthly 0.5 https://novapharmanews.com/apac/news/nasal-sprays-market-29-billion-2036-allergy-growth 2026-06-03T05:21:28.165Z monthly 0.5 https://novapharmanews.com/apac/news/andelyn-biosciences-encell-gene-therapy-manufacturing-partnership 2026-06-03T05:21:30.173Z monthly 0.5 https://novapharmanews.com/apac/news/turbine-crown-bioscience-ai-organoid-cancer-drug-discovery-partnership 2026-06-03T05:21:32.176Z monthly 0.5 https://novapharmanews.com/apac/news/australia-tga-medicinal-cannabis-pediatric-access-guidelines-2024 2026-06-03T05:21:34.169Z monthly 0.5 https://novapharmanews.com/apac/news/australia-tga-unapproved-therapeutic-goods-special-access-scheme-guidance 2026-06-03T05:21:40.116Z monthly 0.5 https://novapharmanews.com/apac/news/ghit-fund-invests-8-5-million-malaria-ntd-drug-development-gsk-eisai 2026-06-03T05:21:38.162Z monthly 0.5 https://novapharmanews.com/apac/news/ghit-fund-8-5-million-malaria-ntd-drug-development-gsk-eisai 2026-06-03T05:21:40.177Z monthly 0.5 https://novapharmanews.com/eu/news/kelun-biotech-sac-tmt-asco-2026-presentations 2026-06-03T05:21:42.183Z monthly 0.5 https://novapharmanews.com/eu/news/prescriberpoint-ai-prior-authorization-platform-clinician-acceptance-rate 2026-06-03T05:21:44.169Z monthly 0.5 https://novapharmanews.com/eu/news/grail-galleri-cancer-detection-asco-2026-results 2026-06-03T05:21:46.176Z monthly 0.5 https://novapharmanews.com/eu/news/eupraxia-pharmaceuticals-positive-resolve-trial-eosinophilic-esophagitis-data 2026-06-03T05:21:54.484Z monthly 0.5 https://novapharmanews.com/eu/news/cellcarta-regask-ai-platform-regulatory-compliance-efficiency 2026-06-03T05:21:55.998Z monthly 0.5 https://novapharmanews.com/eu/news/leerink-partners-medincell-outperform-uzedy-risperidone-lai-fda-approval 2026-06-03T05:21:52.179Z monthly 0.5 https://novapharmanews.com/eu/news/getinge-cardiohelp-ii-ce-mark-intergard-synergy-eu-mdr-approval 2026-06-03T05:21:54.179Z monthly 0.5 https://novapharmanews.com/eu/news/karyopharm-phase-3-sentry-trial-asco-2026-myelofibrosis 2026-06-03T05:21:56.191Z monthly 0.5 https://novapharmanews.com/eu/news/allogene-therapeutics-expands-cemacabtagene-ansegedleucel-alpha3-trial-south-korea-australia 2026-06-03T05:21:58.185Z monthly 0.5 https://novapharmanews.com/eu/news/biocon-health-canada-approval-denosumab-biosimilars-bosaya-vevzuo 2026-06-03T05:22:00.185Z monthly 0.5 https://novapharmanews.com/us/news/francis-medical-vanquish-prostate-ablation-midwest-first-procedure 2026-06-03T05:22:02.186Z monthly 0.5 https://novapharmanews.com/us/news/aquestive-therapeutics-anaphylm-fda-deficiencies-class-action-lawsuit 2026-06-03T05:22:04.209Z monthly 0.5 https://novapharmanews.com/us/news/efemoral-medical-bioresorbable-scaffold-97-percent-patency-peripheral-artery-disease 2026-06-03T05:22:06.206Z monthly 0.5 https://novapharmanews.com/us/news/kyverna-miv-cel-stiff-person-syndrome-trial-results-breakthrough 2026-06-03T05:22:08.185Z monthly 0.5 https://novapharmanews.com/us/news/invera-medical-90-percent-vein-closure-chronic-venous-disease-trial-results 2026-06-03T05:22:11.214Z monthly 0.5 https://novapharmanews.com/us/news/reva-medical-motiv-scaffold-superior-results-critical-limb-ischemia-trial 2026-06-03T05:22:12.201Z monthly 0.5 https://novapharmanews.com/us/news/ractigen-rag-17-als-phase-1-results-neurofilament-reduction 2026-06-03T05:22:19.933Z monthly 0.5 https://novapharmanews.com/us/news/mabwell-nectin-4-adc-bulumtatug-fuvedotin-cervical-cancer-nejm-case-report 2026-06-03T05:22:16.215Z monthly 0.5 https://novapharmanews.com/us/news/outlook-therapeutics-fda-dispute-resolution-lytenava-bevacizumab 2026-06-03T05:22:18.197Z monthly 0.5 https://novapharmanews.com/us/news/follicular-lymphoma-clinical-trials-45-companies-2026 2026-06-03T05:22:21.151Z monthly 0.5 https://novapharmanews.com/us/news/obsidian-therapeutics-obx-115-phase-2-melanoma-asco-2026 2026-06-03T05:22:22.214Z monthly 0.5 https://novapharmanews.com/us/news/icecure-medical-prosense-revenue-increases-30-percent-q1-2026 2026-06-03T05:22:24.225Z monthly 0.5 https://novapharmanews.com/us/news/nuvalent-neladalkib-alkove-1-trial-data-asco-2026-alk-positive-nsclc 2026-06-03T05:22:27.596Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-merck-idvynso-hiv-treatment-doravirine-islatravir 2026-06-03T05:22:32.843Z monthly 0.5 https://novapharmanews.com/apac/news/peptidream-asahi-kasei-ak1940-phase-1-clinical-trial 2026-06-03T05:22:30.211Z monthly 0.5 https://novapharmanews.com/apac/news/rznomics-rz-001-hepatocellular-carcinoma-trial-results-aacr-2026 2026-06-03T05:22:32.222Z monthly 0.5 https://novapharmanews.com/apac/news/biogen-acquires-felzartamab-tj-biopharma-china 2026-06-03T05:22:34.228Z monthly 0.5 https://novapharmanews.com/apac/news/argo-biopharma-bw-40202-phase-ii-trials-sirna-therapy 2026-06-03T05:22:36.216Z monthly 0.5 https://novapharmanews.com/apac/news/mabwell-bioscience-pics-gmp-inspection-denosumab-biosimilars-jordan 2026-06-03T05:22:39.086Z monthly 0.5 https://novapharmanews.com/apac/news/mabwell-t-mab-jordan-gmp-inspection-denosumab-biosimilars-approval 2026-06-03T05:22:40.234Z monthly 0.5 https://novapharmanews.com/apac/news/quality-executive-partners-vienni-virtuosi-india-pharmaceutical-training 2026-06-03T05:22:42.223Z monthly 0.5 https://novapharmanews.com/apac/news/synsmart-amporin-partnership-small-molecule-therapeutics-degenerative-diseases 2026-06-03T05:22:44.239Z monthly 0.5 https://novapharmanews.com/apac/news/australia-tga-otc-medicine-registration-guidelines-update 2026-06-03T05:22:46.230Z monthly 0.5 https://novapharmanews.com/apac/news/methylphenidate-shortage-update-concerta-ritalin-rubifen-supply-2026 2026-06-03T05:22:48.230Z monthly 0.5 https://novapharmanews.com/apac/news/pmda-approves-peripheral-rotablator-pro-visual-ice-cryoablation-system-japan 2026-06-03T05:22:50.236Z monthly 0.5 https://novapharmanews.com/eu/news/cigna-healthcare-imuldosa-biosimilar-preferred-coverage-accord-biopharma 2026-06-03T05:22:52.250Z monthly 0.5 https://novapharmanews.com/eu/news/briacell-bria-ots-phase-3-breast-cancer-quality-life-aacr-2026 2026-06-03T05:22:54.324Z monthly 0.5 https://novapharmanews.com/eu/news/pharmaceutical-isolators-market-782-billion-eu-gmp-annex-1 2026-06-03T05:22:57.723Z monthly 0.5 https://novapharmanews.com/eu/news/mabwell-pics-gmp-compliance-jordan-fda-biopharmaceutical-manufacturing 2026-06-03T05:23:00.701Z monthly 0.5 https://novapharmanews.com/eu/news/implantica-refluxstop-device-safety-study-602-patients-europe 2026-06-03T05:23:00.236Z monthly 0.5 https://novapharmanews.com/eu/news/askbio-ametefgene-parvec-phase-ii-parkinson-gene-therapy 2026-06-03T05:23:02.239Z monthly 0.5 https://novapharmanews.com/us/news/lenz-therapeutics-vizz-presbyopia-uk-mhra-approval-submission 2026-06-03T05:23:04.260Z monthly 0.5 https://novapharmanews.com/us/news/pasithea-pas-004-fda-rare-pediatric-disease-designation-nf1 2026-06-03T05:23:06.266Z monthly 0.5 https://novapharmanews.com/us/news/clearmind-medicine-cmnd-100-safety-endpoint-alcohol-use-disorder-trial 2026-06-03T05:23:08.247Z monthly 0.5 https://novapharmanews.com/us/news/sapience-therapeutics-st316-phase-2-colorectal-cancer-results 2026-06-03T05:23:10.256Z monthly 0.5 https://novapharmanews.com/us/news/tozorakimab-phase-3-miranda-trial-copd-exacerbations-reduction 2026-06-03T05:23:18.662Z monthly 0.5 https://novapharmanews.com/us/news/abogen-abo2203-mrna-cancer-therapy-b-cell-lymphoma-trial-aacr-2026 2026-06-03T05:23:18.333Z monthly 0.5 https://novapharmanews.com/us/news/verismo-synkir-110-phase-1-trial-results-aacr-2026 2026-06-03T05:23:16.265Z monthly 0.5 https://novapharmanews.com/us/news/inhibrx-ozekibart-inbrx-109-colorectal-cancer-clinical-update-webcast 2026-06-03T05:23:20.480Z monthly 0.5 https://novapharmanews.com/us/news/akeso-cadonilimab-pancreatic-cancer-phase-2-trial-results 2026-06-03T05:23:20.277Z monthly 0.5 https://novapharmanews.com/us/news/debiopharm-lunresertib-fda-fast-track-ovarian-cancer 2026-06-03T05:23:22.271Z monthly 0.5 https://novapharmanews.com/us/news/adcendo-adce-t02-expansion-phase-adce-d01-fda-orphan-drug-designation 2026-06-03T05:23:24.281Z monthly 0.5 https://novapharmanews.com/us/news/fda-accepts-genentech-gazyva-lupus-treatment-application 2026-06-03T05:23:26.266Z monthly 0.5 https://novapharmanews.com/us/news/fda-priority-review-padcev-keytruda-bladder-cancer-astellas 2026-06-03T05:23:28.274Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-dermaclear-severe-acne-2026 2026-06-03T05:23:30.285Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-cell-therapy-multiple-sclerosis-2024 2026-06-03T05:23:32.279Z monthly 0.5 https://novapharmanews.com/us/news/fda-biosimilar-substitution-policy-update-2024 2026-06-03T05:23:34.274Z monthly 0.5 https://novapharmanews.com/eu/news/ema-biosimilar-policy-impact-2024 2026-06-03T05:23:36.285Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-paxlovid-covid19-treatment-eua-2024 2026-06-03T05:23:38.298Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-riabni-rituximab-biosimilar-nhl-2024 2026-06-03T05:23:40.283Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-adagrasib-kras-g12c-nsclc-2024 2026-06-03T05:23:42.292Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-apretude-injectable-prep-hiv-2024 2026-06-03T05:23:44.285Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-skin-renew-new-indication-severe-eczema-2024 2026-06-03T05:23:50.803Z monthly 0.5 https://novapharmanews.com/us/news/fda-update-diabetes-therapy-label-warning-2024 2026-06-03T05:23:48.308Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-genopharm-geno-cure-targeted-cancer-2024 2026-06-03T05:23:50.287Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-allerclear-otc-seasonal-allergies-2024 2026-06-03T05:23:52.293Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-bact-away-antibiotic-resistant-infections-2024 2026-06-03T05:23:58.067Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-algorithma-algo-1-trd-2024 2026-06-03T05:23:56.292Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-trial-update-semaglutide-obesity-2024 2026-06-03T05:24:05.636Z monthly 0.5 https://novapharmanews.com/apac/news/alamar-biosciences-nasdaq-ipo-precision-proteomics-debut 2026-06-03T05:24:00.315Z monthly 0.5 https://novapharmanews.com/apac/news/act-genomics-101-gene-panel-cancer-testing-upgrade-2026 2026-06-03T05:24:04.116Z monthly 0.5 https://novapharmanews.com/apac/news/qdenga-dengue-vaccine-approved-australia-tga-four-serotypes 2026-06-03T05:24:04.309Z monthly 0.5 https://novapharmanews.com/eu/news/ema-iris-psur-submission-requirements-september-2025 2026-06-03T05:24:06.314Z monthly 0.5 https://novapharmanews.com/us/news/revolution-medicines-zoldonrasib-phase-1-data-kras-g12d-lung-cancer-aacr-2026 2026-06-03T05:24:08.309Z monthly 0.5 https://novapharmanews.com/us/news/epibiologics-epi-326-phase-1-trial-egfr-cancer 2026-06-03T05:24:10.313Z monthly 0.5 https://novapharmanews.com/us/news/sbc-medical-group-secondary-offering-3-1-million-shares 2026-06-03T05:24:12.313Z monthly 0.5 https://novapharmanews.com/us/news/fda-terminates-gas-delivery-engine-ventilator-recall-16650a 2026-06-03T05:24:14.314Z monthly 0.5 https://novapharmanews.com/us/news/philip-morris-iqos-fda-reauthorization-modified-risk-tobacco-product 2026-06-03T05:24:16.319Z monthly 0.5 https://novapharmanews.com/us/news/ascentage-pharma-preclinical-cancer-studies-aacr-2026 2026-06-03T05:24:18.319Z monthly 0.5 https://novapharmanews.com/us/news/whitehawk-therapeutics-hwk-007-adc-data-aacr-2026 2026-06-03T05:24:20.319Z monthly 0.5 https://novapharmanews.com/us/news/pulnovo-medical-100-million-medtronic-investment-pulmonary-hypertension 2026-06-03T05:24:22.322Z monthly 0.5 https://novapharmanews.com/us/news/nuance-pharma-ohtuvayre-enhance-china-phase-3-copd-results-chest-journal 2026-06-03T05:24:24.324Z monthly 0.5 https://novapharmanews.com/us/news/lundbeck-vyepti-migraine-cognitive-symptoms-infuse-study-2026 2026-06-03T05:24:26.324Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-biosimilar-clone-remicade-2026 2026-06-03T05:24:28.344Z monthly 0.5 https://novapharmanews.com/us/news/fda-priority-review-arterioflow-pad-2024 2026-06-03T05:24:30.348Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-v-protect-vaccine-2026 2026-06-03T05:24:32.339Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-inno-med-inhaler-tech-asthma-2024 2026-06-03T05:24:34.351Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-duo-boost-type-2-diabetes-2024 2026-06-03T05:24:36.337Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-rgen-101-raregen-orphan-drug-2024 2026-06-03T05:24:38.357Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-inflammex-ulcerative-colitis-2026 2026-06-03T05:24:40.342Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-synapton-alzheimers-2026 2026-06-03T05:24:42.341Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-generic-epipen-mylan-2024 2026-06-03T05:24:44.345Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-prevnar-20-pediatric-indication-2024 2026-06-03T05:24:46.349Z monthly 0.5 https://novapharmanews.com/apac/news/zai-lab-zl-1503-bispecific-antibody-itch-relief-atopic-diseases 2026-06-03T05:24:48.347Z monthly 0.5 https://novapharmanews.com/apac/news/zai-lab-zl-1503-bispecific-antibody-atopic-disease-itch-relief-preclinical-data 2026-06-03T05:24:50.351Z monthly 0.5 https://novapharmanews.com/apac/news/antengene-novel-cancer-programs-aacr-2026-adc-tce-therapies 2026-06-03T05:24:52.358Z monthly 0.5 https://novapharmanews.com/apac/news/antengene-adc-antengager-tce-programs-aacr-2026 2026-06-03T05:24:54.358Z monthly 0.5 https://novapharmanews.com/apac/news/australia-tga-therapeutic-vaping-pharmacy-access-regulatory-framework 2026-06-03T05:24:56.375Z monthly 0.5 https://novapharmanews.com/apac/news/tga-medical-device-regulations-ai-software-therapeutic-products-australia 2026-06-03T05:24:58.363Z monthly 0.5 https://novapharmanews.com/eu/news/adagene-muzastotug-triple-combination-therapy-hepatocellular-carcinoma-aacr-2026 2026-06-03T05:25:00.387Z monthly 0.5 https://novapharmanews.com/eu/news/hytn-innovations-hard-cannabis-remediation-technology-gmp-processing-germany 2026-06-03T05:25:02.374Z monthly 0.5 https://novapharmanews.com/eu/news/sanofi-nuvaxovid-covid-vaccine-better-tolerability-mnexspike-phase-4-study 2026-06-03T05:25:04.383Z monthly 0.5 https://novapharmanews.com/eu/news/brand-institute-ema-approval-ai-pharmaceutical-branding-brandi-platform 2026-06-03T05:25:06.381Z monthly 0.5 https://novapharmanews.com/eu/news/ema-drug-patent-cliff-2026-european-exclusivities-expire 2026-06-03T05:25:13.784Z monthly 0.5 https://novapharmanews.com/eu/news/ema-chmp-recommends-six-new-medicines-approval-february-2024 2026-06-03T05:25:13.157Z monthly 0.5 https://novapharmanews.com/eu/news/ema-recommends-adstiladrin-gene-therapy-bladder-cancer-march-2026 2026-06-03T05:25:12.411Z monthly 0.5 https://novapharmanews.com/us/news/health-canada-approves-bracco-vueway-gadopiclenol-mri-contrast 2026-06-03T05:25:14.397Z monthly 0.5 https://novapharmanews.com/us/news/salubris-jk06-phase-1-2-cancer-trial-aacr-2024 2026-06-03T05:25:18.163Z monthly 0.5 https://novapharmanews.com/us/news/innate-pharma-iph5201-matisse-phase-2-aacr-2026-plenary-session 2026-06-03T05:25:24.419Z monthly 0.5 https://novapharmanews.com/us/news/accent-therapeutics-atx-295-kif18a-inhibitor-aacr-2026-cancer-data 2026-06-03T05:25:20.382Z monthly 0.5 https://novapharmanews.com/us/news/zai-lab-zl-1503-bispecific-antibody-atopic-disease-itch-relief 2026-06-03T05:25:22.386Z monthly 0.5 https://novapharmanews.com/us/news/zai-lab-zl-1503-bispecific-antibody-itch-relief-atopic-dermatitis-preclinical 2026-06-03T05:25:24.391Z monthly 0.5 https://novapharmanews.com/us/news/fda-reauthorizes-philip-morris-iqos-modified-risk-tobacco-product 2026-06-03T05:25:33.753Z monthly 0.5 https://novapharmanews.com/us/news/zai-lab-zl-1503-bispecific-antibody-itch-relief-atopic-disease-preclinical-data 2026-06-03T05:25:28.395Z monthly 0.5 https://novapharmanews.com/us/news/olema-oncology-palazestrant-op-3136-preclinical-data-aacr-2026 2026-06-03T05:25:30.395Z monthly 0.5 https://novapharmanews.com/us/news/ucb-acquires-neurona-therapeutics-nrtx-1001-epilepsy-cell-therapy 2026-06-03T05:25:38.419Z monthly 0.5 https://novapharmanews.com/us/news/xodus-medical-fda-clearance-hot-pink-pad-surgical-temperature-management 2026-06-03T05:25:36.023Z monthly 0.5 https://novapharmanews.com/us/news/argenx-vyvgart-myasthenia-gravis-cidp-aan-2026-clinical-data 2026-06-03T05:25:36.399Z monthly 0.5 https://novapharmanews.com/us/news/nuvalent-zidesamtinib-ros1-lung-cancer-aacr-2026 2026-06-03T05:25:38.399Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-verapamil-extended-release-hypertension-2024 2026-06-03T05:25:40.402Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-imgn-901-breakthrough-therapy-aml-2026 2026-06-03T05:25:42.416Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-revitan-gene-therapy-sma-type-3-2026 2026-06-03T05:25:49.747Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-mito-x-accelerated-approval-2024 2026-06-03T05:25:46.413Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-xylocor-refractory-angina-2026 2026-06-03T05:25:48.409Z monthly 0.5 https://novapharmanews.com/apac/news/atara-biotherapeutics-class-action-lawsuit-atra-stockholders-losses 2026-06-03T05:25:50.435Z monthly 0.5 https://novapharmanews.com/eu/news/ema-approves-hanmi-hmpl-523-alzheimer-herbal-medicine 2026-06-03T05:25:52.421Z monthly 0.5 https://novapharmanews.com/eu/news/gene-therapy-market-growth-crispr-aav-technologies-2034 2026-06-03T05:25:54.421Z monthly 0.5 https://novapharmanews.com/eu/news/healthcare-cold-chain-logistics-market-growth-2034-biopharmaceuticals-asia-pacific 2026-06-03T05:25:56.432Z monthly 0.5 https://novapharmanews.com/eu/news/aim-immunotech-ampligen-phase-3-pancreatic-cancer-trial-orphan-drug 2026-06-03T05:25:58.504Z monthly 0.5 https://novapharmanews.com/eu/news/ab-science-masitinib-als-phase-3-trial-insurance-25-million 2026-06-03T05:26:00.435Z monthly 0.5 https://novapharmanews.com/eu/news/meiragTx-acquires-botaretigene-sparoparvovec-gene-therapy-xlrp-johnson-johnson 2026-06-03T05:26:02.429Z monthly 0.5 https://novapharmanews.com/eu/news/beamion-zongertinib-fda-approval-her2-mutant-nsclc-lung-1-study 2026-06-03T05:26:04.457Z monthly 0.5 https://novapharmanews.com/eu/news/tri-611-fda-fast-track-alk-positive-nsclc-eisai-taletrectinib 2026-06-03T05:26:06.438Z monthly 0.5 https://novapharmanews.com/us/news/maia-biotechnology-phase-2-nsclc-telomere-treatment-trial-us-site 2026-06-03T05:26:08.433Z monthly 0.5 https://novapharmanews.com/us/news/dr-falk-pharma-renexxion-naronapride-phase-2b-gastroparesis-ddw-2026 2026-06-03T05:26:10.452Z monthly 0.5 https://novapharmanews.com/us/news/lilly-foundayo-orforglipron-achieve-4-trial-results-mortality-reduction 2026-06-03T05:26:12.433Z monthly 0.5 https://novapharmanews.com/us/news/aicuris-pritelivir-fda-priority-review-herpes-treatment 2026-06-03T05:26:14.433Z monthly 0.5 https://novapharmanews.com/us/news/medera-aav-serca2a-fda-fast-track-duchenne-cardiomyopathy 2026-06-03T05:26:16.436Z monthly 0.5 https://novapharmanews.com/us/news/boehringer-ingelheim-zongertinib-her2-mutant-lung-cancer-nejm-study 2026-06-03T05:26:18.438Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-mindbalance-digital-therapeutic-2026 2026-06-03T05:26:25.633Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-cancervax-adjuvant-melanoma-2026 2026-06-03T05:26:22.437Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-painblock-patch-chronic-pain-2024 2026-06-03T05:26:24.439Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-renalprotect-expanded-use-dkd-2024 2026-06-03T05:26:26.442Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-lungrx-inhaled-therapy-pulmonary-hypertension-2026 2026-06-03T05:26:28.443Z monthly 0.5 https://novapharmanews.com/apac/news/sanyou-ai-stal-2-antibody-discovery-14-days-drug-development 2026-06-03T05:26:30.465Z monthly 0.5 https://novapharmanews.com/apac/news/gene-expression-analysis-market-593-billion-2031-drug-discovery 2026-06-03T05:26:32.452Z monthly 0.5 https://novapharmanews.com/apac/news/perceptive-discovery-mh3d-alpha-sight-radiopharmaceutical-imaging 2026-06-03T05:26:34.460Z monthly 0.5 https://novapharmanews.com/apac/news/pg-health-apac-pharmacist-guidelines-peripheral-neuropathy-management 2026-06-03T05:26:36.455Z monthly 0.5 https://novapharmanews.com/apac/news/tga-assessed-listed-medicines-framework-update-australia 2026-06-03T05:26:38.470Z monthly 0.5 https://novapharmanews.com/apac/news/corcept-therapeutics-relacorilant-fda-rejection-investor-lawsuit-2025 2026-06-03T05:26:40.459Z monthly 0.5 https://novapharmanews.com/apac/news/florida-cancer-specialists-medically-integrated-oncology-care-2024 2026-06-03T05:26:42.464Z monthly 0.5 https://novapharmanews.com/eu/news/traws-pharma-tivoxavir-marboxil-influenza-trial-ratutrelvir-covid-results-2025 2026-06-03T05:26:44.477Z monthly 0.5 https://novapharmanews.com/eu/news/tme-pharma-nox-a12-triple-therapy-brain-cancer-gloria-trial-nature-communications 2026-06-03T05:26:46.481Z monthly 0.5 https://novapharmanews.com/eu/news/additional-risk-minimization-measures-armms-training-course-patient-safety 2026-06-03T05:26:48.475Z monthly 0.5 https://novapharmanews.com/eu/news/healthcare-logistics-market-growth-159-billion-2030-biopharmaceutical-cold-chain 2026-06-03T05:26:59.766Z monthly 0.5 https://novapharmanews.com/eu/news/medical-device-software-compliance-training-eu-mdr-ivdr-fda-june-2026 2026-06-03T05:26:52.479Z monthly 0.5 https://novapharmanews.com/eu/news/onward-medical-40-million-capital-increase-eqt-life-sciences 2026-06-03T05:26:54.485Z monthly 0.5 https://novapharmanews.com/eu/news/sahpra-african-medicines-agency-regulatory-harmonization-course-may-2026 2026-06-03T05:26:56.484Z monthly 0.5 https://novapharmanews.com/eu/news/bavarian-nordic-vimkunya-chikungunya-vaccine-swiss-approval-swissmedic 2026-06-03T05:26:58.487Z monthly 0.5 https://novapharmanews.com/eu/news/seragon-srn-901-longevity-drug-lifespan-extension-preclinical-study 2026-06-03T05:27:00.497Z monthly 0.5 https://novapharmanews.com/us/news/fda-food-additive-contact-substance-regulatory-updates-2026 2026-06-03T05:27:02.485Z monthly 0.5 https://novapharmanews.com/us/news/recognition-health-alzheimers-blood-test-clinical-trial-2026 2026-06-03T05:27:04.503Z monthly 0.5 https://novapharmanews.com/us/news/mabwell-maiweijian-denosumab-nmpa-acceptance-cancer-bone-metastases 2026-06-03T05:27:06.517Z monthly 0.5 https://novapharmanews.com/us/news/sedogen-diazoxide-patent-prader-willi-syndrome-behavioral-symptoms 2026-06-03T05:27:08.488Z monthly 0.5 https://novapharmanews.com/us/news/mabwell-lilrb4-cd3-bispecific-antibody-6mw5311-nmpa-ind-approval-leukemia 2026-06-03T05:27:10.494Z monthly 0.5 https://novapharmanews.com/us/news/mabwell-maiweijian-denosumab-nmpa-acceptance-cancer-bone-treatment 2026-06-03T05:27:12.508Z monthly 0.5 https://novapharmanews.com/us/news/thinktrends-ai-federal-health-agency-adverse-event-monitoring-system 2026-06-03T05:27:14.512Z monthly 0.5 https://novapharmanews.com/us/news/fullscript-journeys-digital-health-platform-launch-2024 2026-06-03T05:27:16.498Z monthly 0.5 https://novapharmanews.com/us/news/nexalin-technology-fda-alzheimers-strategy-meetings-china-us 2026-06-03T05:27:18.515Z monthly 0.5 https://novapharmanews.com/us/news/immunitybio-ibrx-fda-warning-letter-class-action-lawsuit-ankt 2026-06-03T05:27:20.517Z monthly 0.5 https://novapharmanews.com/us/news/fda-warning-letters-pharmaceutical-compliance-drug-safety-2024 2026-06-03T05:27:22.512Z monthly 0.5 https://novapharmanews.com/us/news/gsk-depemokimab-european-chinese-approval-ultra-long-acting-biologic 2026-06-03T05:27:24.521Z monthly 0.5 https://novapharmanews.com/us/news/elion-therapeutics-turletricin-phase-2-trial-invasive-mold-infections 2026-06-03T05:27:26.529Z monthly 0.5 https://novapharmanews.com/us/news/glaukos-epioxa-permanent-j-code-j2789-cms-approval 2026-06-03T05:27:28.524Z monthly 0.5 https://novapharmanews.com/us/news/nkarta-fda-approval-outpatient-nkx019-dosing-autoimmune-disease 2026-06-03T05:27:30.514Z monthly 0.5 https://novapharmanews.com/apac/news/phantom-neuro-phantom-x-first-human-trial-approval-australia 2026-06-03T05:27:32.517Z monthly 0.5 https://novapharmanews.com/eu/news/boehringer-ingelheim-zai-lab-dll3-targeting-combination-therapy-small-cell-lung-cancer-trial 2026-06-03T05:27:34.517Z monthly 0.5 https://novapharmanews.com/eu/news/imvt-1402-myasthenia-gravis-treatment-pipeline-2026 2026-06-03T05:27:36.520Z monthly 0.5 https://novapharmanews.com/us/news/dogwood-therapeutics-sp16-fda-ind-approval-chemotherapy-pain 2026-06-03T05:27:38.522Z monthly 0.5 https://novapharmanews.com/us/news/pds-biotech-pds01adc-78-percent-response-rate-colorectal-cancer-phase-2 2026-06-03T05:27:40.523Z monthly 0.5 https://novapharmanews.com/us/news/neffy-epinephrine-nasal-spray-approved-canada-needle-free-anaphylaxis-treatment 2026-06-03T05:27:42.528Z monthly 0.5 https://novapharmanews.com/us/news/cala-fda-clearance-kiq-plus-wearable-device-essential-tremor-parkinsons 2026-06-03T05:27:44.531Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-rapiblyk-landiolol-pediatric-svt-aop-health 2026-06-03T05:27:46.558Z monthly 0.5 https://novapharmanews.com/us/news/asco-2026-gi-innovation-gi-101a-phase-1-data-preview 2026-06-03T05:27:48.539Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-sleepwell-chronic-insomnia-2026 2026-06-03T05:27:50.544Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-nanopharm-metastatic-breast-cancer-2024 2026-06-03T05:27:52.557Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-fluguard-novel-influenza-vaccine-2026 2026-06-03T05:27:54.539Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-cardiodetect-ai-diagnostic-arrhythmia-2026 2026-06-03T05:27:56.540Z monthly 0.5 https://novapharmanews.com/apac/news/phrontline-biopharma-tj106-her2-adc-preclinical-data-aacr-2026 2026-06-03T05:27:58.537Z monthly 0.5 https://novapharmanews.com/apac/news/xellsmart-xs411-parkinsons-cell-therapy-phase-ii-trial-2026 2026-06-03T05:28:00.556Z monthly 0.5 https://novapharmanews.com/apac/news/peer-ai-regulatory-platform-predictive-intelligence-life-sciences 2026-06-03T05:28:02.549Z monthly 0.5 https://novapharmanews.com/apac/news/wuxi-biologics-iso-13485-certification-drug-device-combination-products 2026-06-03T05:28:04.661Z monthly 0.5 https://novapharmanews.com/apac/news/atelerix-jh-health-partnership-cell-preservation-middle-east 2026-06-03T05:28:06.549Z monthly 0.5 https://novapharmanews.com/apac/news/chitosan-market-growth-kitozyme-primex-pharmaceutical-biopolymer-2036 2026-06-03T05:28:08.564Z monthly 0.5 https://novapharmanews.com/apac/news/telix-tlx101-tx-phase-3-glioblastoma-trial-first-patient 2026-06-03T05:28:10.557Z monthly 0.5 https://novapharmanews.com/apac/news/nmn-500mg-energy-support-tga-approval-australia 2026-06-03T05:28:12.554Z monthly 0.5 https://novapharmanews.com/eu/news/drug-development-services-market-31-billion-2026-pharma-rd-investments 2026-06-03T05:28:14.564Z monthly 0.5 https://novapharmanews.com/eu/news/medicenna-bizaxofusp-brain-cancer-trials-2026-investor-conference 2026-06-03T05:28:16.573Z monthly 0.5 https://novapharmanews.com/eu/news/vitestro-autonomous-robotic-phlebotomy-device-clinical-trial-results 2026-06-03T05:28:18.572Z monthly 0.5 https://novapharmanews.com/eu/news/grace-therapeutics-gtx-104-phase-3-strive-on-trial-aan-2026 2026-06-03T05:28:20.564Z monthly 0.5 https://novapharmanews.com/eu/news/mena-medical-device-regulatory-training-course-may-2026 2026-06-03T05:28:22.597Z monthly 0.5 https://novapharmanews.com/eu/news/cmo-cdmo-market-growth-biologics-manufacturing-2035 2026-06-03T05:28:24.565Z monthly 0.5 https://novapharmanews.com/eu/news/clinical-trial-monitoring-gcp-compliance-course-2026 2026-06-03T05:28:26.568Z monthly 0.5 https://novapharmanews.com/eu/news/gcp-inspections-training-course-ich-e6-r3-eu-ctr-compliance-july-2026 2026-06-03T05:28:28.569Z monthly 0.5 https://novapharmanews.com/eu/news/vabysmo-market-report-2026-roche-eye-drug-growth-forecast 2026-06-03T05:28:30.574Z monthly 0.5 https://novapharmanews.com/eu/news/glyconex-gnx1021-pmda-approval-phase-1-trial-gastrointestinal-cancers 2026-06-03T05:28:32.578Z monthly 0.5 https://novapharmanews.com/us/news/psoriasis-clinical-trial-pipeline-90-companies-2026 2026-06-03T05:28:34.579Z monthly 0.5 https://novapharmanews.com/us/news/meiragTx-aav-haqp1-gene-therapy-xerostomia-3-year-data-april-2026 2026-06-03T05:28:36.580Z monthly 0.5 https://novapharmanews.com/us/news/corbus-pharmaceuticals-crb-913-obesity-drug-canyon-1-trial-enrollment-complete 2026-06-03T05:28:38.589Z monthly 0.5 https://novapharmanews.com/us/news/actuate-therapeutics-elraglusib-pancreatic-cancer-survival-nature-medicine 2026-06-03T05:28:40.605Z monthly 0.5 https://novapharmanews.com/us/news/dupont-amberchrom-xt-sl-chromatography-resins-biopharmaceutical-manufacturing 2026-06-03T05:28:42.615Z monthly 0.5 https://novapharmanews.com/us/news/vasa-therapeutics-lilly-tunelab-ai-camkii-inhibitor-partnership 2026-06-03T05:28:50.270Z monthly 0.5 https://novapharmanews.com/us/news/synusight-biotech-sst001-alpha-synuclein-pet-tracer-nmpa-approval-phase-1-trial 2026-06-03T05:28:46.617Z monthly 0.5 https://novapharmanews.com/us/news/oryon-cell-therapies-appoints-burkhard-blank-chief-medical-officer 2026-06-03T05:28:48.621Z monthly 0.5 https://novapharmanews.com/us/news/amneal-launches-albuterol-beclomethasone-respiratory-inhalers-2026 2026-06-03T05:28:50.595Z monthly 0.5 https://novapharmanews.com/us/news/bright-path-fy2027-budget-domestic-pharmaceutical-manufacturing 2026-06-03T05:28:52.602Z monthly 0.5 https://novapharmanews.com/us/news/partner-therapeutics-bizengri-fda-application-cholangiocarcinoma-nrg1-fusion 2026-06-03T05:28:54.602Z monthly 0.5 https://novapharmanews.com/us/news/clearmind-medicine-cmnd-100-alcohol-use-disorder-trial-results 2026-06-03T05:29:01.024Z monthly 0.5 https://novapharmanews.com/us/news/praxis-precision-medicines-fda-accepts-ulixacaltamide-hcl-essential-tremor-nda 2026-06-03T05:28:58.613Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-filspari-sparsentan-fsgs-first-treatment-rare-kidney-disease 2026-06-03T05:29:00.629Z monthly 0.5 https://novapharmanews.com/us/news/apotex-fda-approval-generic-infuvite-adult-injection-exclusivity 2026-06-03T05:29:02.698Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-orphan-drug-rarecure-ert-2026 2026-06-03T05:29:04.630Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-migraease-new-migraine-drug-2024 2026-06-03T05:29:06.638Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-expanded-indication-elahere-2024 2026-06-03T05:29:08.616Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-cardioshield-hfpef-2026 2026-06-03T05:29:10.618Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-vitacorp-antibiotic-priority-review-2024 2026-06-03T05:29:12.617Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-neurovance-xr-pediatric-adhd-2026 2026-06-03T05:29:14.636Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-lumagen-gene-therapy-2024 2026-06-03T05:29:16.630Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-biosimilar-insulin-lispro-biosolve-2026 2026-06-03T05:29:18.640Z monthly 0.5 https://novapharmanews.com/us/news/fda-accelerated-approval-oncocure-trk-inhibitor-2024 2026-06-03T05:29:20.622Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-cart-t20-car-t-therapy-mantle-cell-lymphoma-2026 2026-06-03T05:29:22.630Z monthly 0.5 https://novapharmanews.com/eu/news/ema-implement-ai-system-drug-safety-2024 2026-06-03T05:29:24.630Z monthly 0.5 https://novapharmanews.com/eu/news/european-commission-launches-blockchain-pilot-pharmaceutical-supply-chain-2024 2026-06-03T05:29:26.651Z monthly 0.5 https://novapharmanews.com/apac/news/nmepa-priority-review-ai-diagnostic-early-cancer-2024 2026-06-03T05:29:28.634Z monthly 0.5 https://novapharmanews.com/apac/news/pmda-approval-ai-platform-personalized-medicine-oncology-2024 2026-06-03T05:29:30.634Z monthly 0.5 https://novapharmanews.com/us/news/fda-launches-blockchain-pilot-program-pharmaceutical-supply-chain-2024 2026-06-03T05:29:32.640Z monthly 0.5 https://novapharmanews.com/us/news/fda-implement-ai-powered-expedited-drug-review-2027 2026-06-03T05:29:41.259Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-renoprotect-diabetic-kidney-disease-therapy-2024 2026-06-03T05:29:36.643Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-airflow-inhalable-severe-asthma-2026 2026-06-03T05:29:38.666Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-osteobuild-bone-building-agent-severe-osteoporosis-2026 2026-06-03T05:29:40.657Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-arterioflow-peripheral-artery-disease-2026 2026-06-03T05:29:50.171Z monthly 0.5 https://novapharmanews.com/us/news/fda-priority-review-cholesterolrx-high-cholesterol-2024 2026-06-03T05:29:48.823Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-opti-sight-glaucoma-2026 2026-06-03T05:29:46.649Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-microbalance-crohns-disease-2026 2026-06-03T05:29:48.660Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-somnirestore-chronic-insomnia-2026 2026-06-03T05:29:50.672Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-neurobloc-non-opioid-pain-reliever-2026 2026-06-03T05:29:52.662Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-lysoclear-lysosomal-storage-disorders-2026 2026-06-03T05:29:54.665Z monthly 0.5 https://novapharmanews.com/eu/news/ema-conditional-approval-car-t-relapsed-b-cell-lymphoma-2024 2026-06-03T05:29:56.660Z monthly 0.5 https://novapharmanews.com/us/news/fda-breakthrough-therapy-targtex-tx202-glioblastoma-2024 2026-06-03T05:29:58.669Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-bria-cell-bria-imt-car-t-therapy-advanced-breast-cancer-2024 2026-06-03T05:30:00.687Z monthly 0.5 https://novapharmanews.com/eu/news/ema-positive-opinion-zepzelca-lurbinectedin-cancer-treatment 2026-06-03T05:30:02.682Z monthly 0.5 https://novapharmanews.com/eu/news/ema-positive-opinion-amgen-tarlatamab-imdylltra-small-cell-lung-cancer 2026-06-03T05:30:04.691Z monthly 0.5 https://novapharmanews.com/eu/news/ema-positive-opinion-adstiladrin-gene-therapy-bladder-cancer 2026-06-03T05:30:06.677Z monthly 0.5 https://novapharmanews.com/eu/news/ema-recommends-imdylltra-tarlatamab-small-cell-lung-cancer-approval 2026-06-03T05:30:08.694Z monthly 0.5 https://novapharmanews.com/eu/news/ema-virtual-control-groups-reduce-animal-testing-drug-development 2026-06-03T05:30:10.682Z monthly 0.5 https://novapharmanews.com/us/news/fda-manufacturing-precheck-pilot-program-streamline-oversight 2026-06-03T05:30:12.692Z monthly 0.5 https://novapharmanews.com/us/news/real-world-evidence-transforms-drug-development-fda-regulatory-framework 2026-06-03T05:30:14.687Z monthly 0.5 https://novapharmanews.com/us/news/fda-untitled-letters-pharmaceutical-marketing-violations-database 2026-06-03T05:30:16.687Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-higher-dose-wegovy-7-2mg-weight-loss-priority-review 2026-06-03T05:30:18.683Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-avlayah-hunter-syndrome-neurologic-treatment 2026-06-03T05:30:20.694Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-kresladi-first-gene-therapy-lad-i-leukocyte-adhesion-deficiency 2026-06-03T05:30:22.700Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-foundayo-orforglipron-priority-voucher-program 2026-06-03T05:30:24.694Z monthly 0.5 https://novapharmanews.com/eu/news/ema-analysis-ai-pharma-rd-investment-2024 2026-06-03T05:30:26.772Z monthly 0.5 https://novapharmanews.com/eu/news/ema-accelerated-assessment-novel-mrna-vaccine-platforms-2024 2026-06-03T05:30:28.703Z monthly 0.5 https://novapharmanews.com/eu/news/ema-approval-gene-therapies-neurological-disorders-2024 2026-06-03T05:30:30.708Z monthly 0.5 https://novapharmanews.com/eu/news/ema-clinical-trials-regulation-rare-disease-2026 2026-06-03T05:30:32.714Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-dermtech-skinguard-severe-eczema-2026 2026-06-03T05:30:34.723Z monthly 0.5 https://novapharmanews.com/eu/news/ema-blockchain-pharmaceutical-supply-chain-2024 2026-06-03T05:30:45.200Z monthly 0.5 https://novapharmanews.com/eu/news/ema-gdpr-impact-pharmaceutical-data-2024 2026-06-03T05:30:38.707Z monthly 0.5 https://novapharmanews.com/apac/news/nmpa-data-integrity-requirements-guide-2024 2026-06-03T05:30:40.707Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-cognimax-alzheimers-2026 2026-06-03T05:30:42.714Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-vitarestrore-age-related-macular-degeneration-2026 2026-06-03T05:30:44.711Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-nasoclear-pediatric-rsv-2026 2026-06-03T05:30:46.725Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-revitalize-chronic-fatigue-syndrome-2026 2026-06-03T05:31:01.112Z monthly 0.5 https://novapharmanews.com/eu/news/ema-ai-powered-clinical-trial-matching-patient-recruitment-2024 2026-06-03T05:30:50.725Z monthly 0.5 https://novapharmanews.com/eu/news/ema-regulatory-outlook-digital-therapeutics-europe-2024 2026-06-03T05:30:59.671Z monthly 0.5 https://novapharmanews.com/apac/news/nmpa-ai-clinical-trial-matching-china-2024 2026-06-03T05:30:54.725Z monthly 0.5 https://novapharmanews.com/apac/news/nmpa-telemedicine-apac-opportunities-challenges-2024 2026-06-03T05:30:56.723Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-genecorrect-gene-therapy-cystic-fibrosis-2026 2026-06-03T05:30:58.728Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-myorepair-breakthrough-therapy-2026 2026-06-03T05:31:00.942Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-oncoblock-refractory-aml-2024 2026-06-03T05:31:02.851Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-xylocor-nda-advanced-melanoma-2024 2026-06-03T05:31:10.230Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-repatha-evolocumab-cardiovascular-prevention-2024 2026-06-03T05:31:06.848Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-tecentriq-atezolizumab-es-sclc-2024 2026-06-03T05:31:08.859Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-opdivo-nivolumab-advanced-rcc-2024 2026-06-03T05:31:10.850Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-keytruda-adjuvant-stage-iii-melanoma-2024 2026-06-03T05:31:12.857Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-aduhelm-alzheimers-2021 2026-06-03T05:31:14.857Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-dupixent-eosinophilic-esophagitis-2024 2026-06-03T05:31:16.874Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-johnson-johnson-stelara-ulcerative-colitis-2024 2026-06-03T05:31:18.876Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-imfinzi-durvalumab-stage-iii-nsclc-2024 2026-06-03T05:31:20.863Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-trikafta-cystic-fibrosis-children-2024 2026-06-03T05:31:26.859Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-mounjaro-weight-management-2024 2026-06-03T05:31:24.865Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-cosentyx-hidradenitis-suppurativa-2024 2026-06-03T05:34:05.112Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-moderna-mrna-1345-rsv-vaccine-2024 2026-06-03T05:31:30.288Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-zithromax-pediatric-cap-2026 2026-06-03T05:31:30.882Z monthly 0.5 https://novapharmanews.com/us/news/fda-priority-review-revivcor-etanercept-biosimilar-heart-failure-2024 2026-06-03T05:31:32.938Z monthly 0.5 https://novapharmanews.com/apac/news/nmpa-breakthrough-innovent-kras-g12c-inhibitor-2024 2026-06-03T05:31:36.381Z monthly 0.5 https://novapharmanews.com/apac/news/pmda-accepts-shionogi-influenza-drug-sakigake-2024 2026-06-03T05:31:36.901Z monthly 0.5 https://novapharmanews.com/apac/news/cdsco-policy-changes-generics-market-growth-india-2024 2026-06-03T05:31:38.894Z monthly 0.5 https://novapharmanews.com/apac/news/pmda-sakigake-designation-regenerative-medicine-market-access-2024 2026-06-03T05:31:40.910Z monthly 0.5 https://novapharmanews.com/apac/news/nmpa-priority-review-pathway-innovative-drug-approvals-2024 2026-06-03T05:31:42.878Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-lumasiran-acute-hepatic-porphyria-2026 2026-06-03T05:31:44.883Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-inhalex-copd-2026 2026-06-03T05:31:46.885Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-rapiclot-tranexamic-acid-trauma-2026 2026-06-03T05:31:48.891Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-tarzenta-advanced-her2-negative-breast-cancer-2024 2026-06-03T05:31:50.891Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-ritempro-parkinsons-2026 2026-06-03T05:31:59.196Z monthly 0.5 https://novapharmanews.com/apac/news/pmda-expedited-review-novel-melanoma-therapies-2024 2026-06-03T05:31:54.892Z monthly 0.5 https://novapharmanews.com/apac/news/tga-innovation-report-australian-biotech-solid-tumor-car-t-2024 2026-06-03T05:31:56.899Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-tevimbra-tislelizumab-escc-2024 2026-06-03T05:31:58.900Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-wainua-eplontersen-hattr-pn-2024 2026-06-03T05:32:00.915Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-sanofi-altuviiio-hemophilia-a-2024 2026-06-03T05:32:02.910Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-augtyro-repotrectinib-ros1-nsclc-2024 2026-06-03T05:32:04.936Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-litfulo-ritlecitinib-alopecia-2024 2026-06-03T05:32:06.901Z monthly 0.5 https://novapharmanews.com/apac/news/nmpa-gmp-standards-foreign-manufacturers-impact-2024 2026-06-03T05:32:08.909Z monthly 0.5 https://novapharmanews.com/eu/news/mhra-vs-ema-regulatory-pathway-strategy-2024 2026-06-03T05:32:10.912Z monthly 0.5 https://novapharmanews.com/eu/news/ema-market-analysis-orphan-drug-pricing-reimbursement-2024 2026-06-03T05:32:12.995Z monthly 0.5 https://novapharmanews.com/apac/news/nmpa-accelerated-approval-orphan-drugs-impact-future-trends-2024 2026-06-03T05:32:14.913Z monthly 0.5 https://novapharmanews.com/apac/news/ich-guidelines-biosimilar-development-apac-2024 2026-06-03T05:32:16.919Z monthly 0.5 https://novapharmanews.com/apac/news/cdsco-forecasting-biosimilar-market-growth-india-2024 2026-06-03T05:32:18.921Z monthly 0.5 https://novapharmanews.com/apac/news/tga-pmda-uptake-adalimumab-biosimilars-2024 2026-06-03T05:32:27.962Z monthly 0.5 https://novapharmanews.com/apac/news/pmda-biosimilar-framework-trastuzumab-adoption-2024 2026-06-03T05:32:22.931Z monthly 0.5 https://novapharmanews.com/apac/news/nmpa-biosimilar-approval-pathway-analysis-2024 2026-06-03T05:32:24.923Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-repatha-pediatric-hefh-2024 2026-06-03T05:32:26.941Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-adzynma-thrombotic-thrombocytopenic-purpura-2024 2026-06-03T05:32:28.945Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-otc-naloxone-nasal-spray-opioid-overdose-2024 2026-06-03T05:32:30.936Z monthly 0.5 https://novapharmanews.com/us/news/fda-priority-review-sotorasib-kras-g12c-nsclc-2024 2026-06-03T05:32:32.934Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-veozah-fezolinetant-menopause-2024 2026-06-03T05:32:34.950Z monthly 0.5 https://novapharmanews.com/apac/news/nmpa-pmda-tga-pompe-disease-market-analysis-2024 2026-06-03T05:32:36.938Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-omidubicel-onlv-2026 2026-06-03T05:32:38.940Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-updated-covid19-vaccines-fall-2024 2026-06-03T05:32:40.937Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-bosulif-pediatric-cml-2024 2026-06-03T05:32:42.956Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-ztalmy-ganaxolone-cdkl5-deficiency-2024 2026-06-03T05:32:44.941Z monthly 0.5 https://novapharmanews.com/eu/news/ema-impact-eu-pharmaceutical-strategy-api-manufacturing-2024 2026-06-03T05:32:46.945Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-opdivo-nivolumab-gastric-cancer-2024 2026-06-03T05:32:48.953Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-breyanzi-car-t-mantle-cell-lymphoma-2024 2026-06-03T05:32:50.949Z monthly 0.5 https://novapharmanews.com/us/news/fda-accelerated-approval-mirvetuximab-soravtansine-elahere-2026 2026-06-03T05:32:52.951Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-elarek-osteoporosis-prevention-2026 2026-06-03T05:32:55.027Z monthly 0.5 https://novapharmanews.com/eu/news/ema-legislation-reform-market-access-innovation-2024 2026-06-03T05:32:56.954Z monthly 0.5 https://novapharmanews.com/apac/news/nmpa-approval-bevacizumab-biosimilar-china-2024 2026-06-03T05:32:58.978Z monthly 0.5 https://novapharmanews.com/eu/news/ema-marketing-authorization-denosumab-biosimilar-2024 2026-06-03T05:33:00.957Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-interchangeable-biosimilar-ustekinumab-2024 2026-06-03T05:33:02.971Z monthly 0.5 https://novapharmanews.com/eu/news/chmp-positive-opinion-car-t-therapy-relapsed-b-cell-lymphoma-2024 2026-06-03T05:33:04.973Z monthly 0.5 https://novapharmanews.com/eu/news/ema-legislation-reform-biopharma-innovation-2024 2026-06-03T05:33:06.967Z monthly 0.5 https://novapharmanews.com/apac/news/tga-australia-early-phase-trials-analysis-2024 2026-06-03T05:33:08.967Z monthly 0.5 https://novapharmanews.com/eu/news/ema-artificial-intelligence-clinical-trials-guidelines-2024 2026-06-03T05:33:10.977Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-anti-inflammatory-atopic-dermatitis-2024 2026-06-03T05:34:04.969Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-amgen-bispecific-antibody-colorectal-cancer-2024 2026-06-03T05:33:17.048Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-syfovre-geographic-atrophy-2023 2026-06-03T05:33:16.994Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-endeavorrx-digital-therapeutic-adhd-2024 2026-06-03T05:33:18.987Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-roche-ntrk-fusion-therapy-2024 2026-06-03T05:33:23.991Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-casgevy-gene-therapy-sickle-cell-2023 2026-06-03T05:33:22.987Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-humira-biosimilar-interchangeable-2023 2026-06-03T05:33:28.301Z monthly 0.5 https://novapharmanews.com/us/news/fda-approval-gilead-hiv-bimonthly-treatment-2024 2026-06-03T05:33:27.009Z monthly 0.5 https://novapharmanews.com/us/news/fda-priority-review-astrazeneca-wilson-disease-2024 2026-06-03T05:33:28.995Z monthly 0.5 https://novapharmanews.com/us/news/fda-accelerated-approval-donanemab-alzheimers-2024 2026-06-03T05:33:30.997Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-novartis-breast-cancer-treatment-2024 2026-06-03T05:33:33.024Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-lumakras-nsclc-2023 2026-06-03T05:33:35.009Z monthly 0.5 https://novapharmanews.com/us/news/fda-approves-talquetamab-multiple-myeloma-2024 2026-06-03T05:33:37.007Z monthly 0.5